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ABSTRACT 
 
 The development and investigation of a new affinity proteomics probe and methodology 
are presented in this dissertation.  A trifunctional affinity proteomics probe (TAPP) was 
envisioned and prepared to serve as a lectin capture reagent.  The TAPP consists of a solid 
support to serve as a handle for captured protein as well as scaffold for multivalency, a 
saccharide of interest to fish for an unknown or elicit a suspected specific interaction, and a 
photoactivated cross-linking moiety to covalently capture binding proteins.  The perfluorinated 
phenylazide cross-linker was shown to exhibit better performance relative to the parent 
phenylazide  with respect to sensitivity and selectively for specific and nonspecific interactions.  
The synthetic strategy included coupling of the saccharide signal as late as possible in the 
preparation to allow for ease of diversification of the saccharide signal.  Such a strategy could be 
exploited with automated combinatorial chemical synthesis of oligosaccharides to quickly build 
a diverse series of probes for study.  Synthesis of several galactose and galactosamine based 
monosaccharide donors are presented in this dissertation with the potential to be used to create 
an array of six oligosaccharides from the nematode Caenorhabditis elegans.  Solution phase, 
automated synthesis was employed to test the building blocks, and to investigate current methods 
to accomplish the formation of a 3,4,6 glycosidic branching pattern on a singular 
monosaccharide unit.  Results suggest such a glycosylation reaction is, indeed, possible. 
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CHAPTER I 
 REVIEW OF GLYCAN FUNCTIONS AND LIMITATIONS OF THEIR STUDY 
 
 
General Introduction 
 
Very few roles of carbohydrates in biological systems are well understood or known 
(Varki 2009).  General knowledge may consider them as being functionally insignificant 
structural feature of proteins and DNA, or as an energy source (Lee 2006, Lee 2009, Varki 
2009).  The roles of carbohydrates in biological systems are much broader and are in many cases, 
critical to the proper functions of these carbohydrate containing structures, or glycoconjugates 
(Figure 1.1) (Elbein 1991,  Lee 2009, Öberg 2011).   Glycans, the carbohydrate portion of a 
glycoconjugate, are found as constituents of all other well studied biological macromolecules: 
lipids, proteins, and nucleic acids (Varki 2009).  While ubiquitous in biological systems, 
carbohydrate study lags significantly behind in understanding relevant or important structural 
and/or functional features compared to proteins and nucleic acids.  Interest in glycomics is 
growing among the scientific community and considerable efforts have been made to elucidate 
the biological relevance of glycans (Lee 2006,  Lee 2009) .  Glycans have been implicated to 
contribute to molecular recognition, cell-cell recognition and adhesion, and cell signaling 
functions that are vital for cell proliferation as well as pathogen infection in hosts (Disney 2004, 
Gama 2006, Green 2007, Lee 2009).  The study of this class of biomolecules remains a 
significant challenge for many reasons; methodologies for probing these interactions suffer many 
limitations and obtaining carbohydrates of interest is not a trivial task.   
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Figure 1.1  General overview of some glycan roles in living systems.  Hexagons 
represent generic monosaccharide units, this figure does not represent any specific interaction.  
Figure adapted from www.biochem.emory.edu/glycomicscenter. 
 
Current Methods and Limitations 
 
Identification of carbohydrate roles in biological systems have shown that glycans 
frequently act as substrates for lectins or bacterial adhesins (Berthet 2012).  Lectins are proteins 
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that have a binding motif that binds selectively to specific carbohydrates and are considered to be 
the foremost interaction between cells with other cells directly or indirectly, such as interactions 
mediated by antibodies (Green 2007), .  Similarly, bacterial adhesins are found on the surface of 
bacterial cells, and also are responsible for mediating cellular adhesion, which is regarded as the 
first essential step to pathogen infection (Rohde 2013).  Identification of the binding pairs 
responsible for these interactions facilitates the development of therapeutics with applications 
ranging from treatment of autoimmune disorders (Green 2007) to attenuating pathogen infections 
(Pieters 2007).  To this end, methods have been developed, however they are limited by several 
factors. 
Many of the interactions of interest take place on the surface of a cell, and as a result, the 
protein or glycan involved in the interaction is usually tethered to the cell as part of a larger 
complex.  Proteins are typically pili or fimbriae bound making isolation for identification 
problematic because these sorts of protein complexes do not resolve very well with methods like 
gel electrophoresis (Ilver 2003), the structural conformation may change in solution, and 
solubility issues can also occur (Smith 2011). Glycans involved in recognition events are 
typically glycolipids or glycoproteins.  The sheer heterogeneity of glycolipids make them very 
difficult to analyze as mixtures, but methods have been used to do so.   However, these methods 
are prone to miss identifications due to loss of multivalency or poor resolution and mis-
identification of the signal (Ilver 2003).   The glycans present on a glycoprotein are heterogenic, 
so after binding is shown, the binding glycan remains ambiguous.  Subsequent fractionation of 
the glycoprotein to isolate the individual carbohydrates results in loss of multivalency and thus 
binding avidity (Ilver 2003).   
 
4 
 
 
Multivalency has been described as the multiple interactions between two entities arising 
from an identical signal and receptor pair (Krishnamurthy 2006).  Due to the cooperative effects  
 
Figure 1.2  Comparison of monovalency to multivalency.  Figure adapted from 
Krishnamurthy 2006. 
 
of multiple binding events, the observed binding between two bodies is much greater than the 
individual affinity for each signal/receptor interaction.  Literature uses the dissociation constant, 
kd, as a measurement for host/guest binding (Figure 1.2)(Kitov 2003, Krishnamurthy 2006).  A 
typical kd for monovalent interactions, described as kdaffinity, is on the order of mM to µM.  The 
observed multivalent interaction, kdavidity, will typically be on the order of nM (Krishnamurthy 
2006).  Briefly, the enhancement of the binding affinity is thought to arise from the idea that 
each binding event will produce the nearly similar enthalpic stabilization while the entropic  
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Figure 1.3  General explanation of enhanced binding in multivalent systems. 
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penalty is greatly reduced after the initial binding event, and mildly reduced after each 
subsequent binding event for a multivalent host guest pair (Figure 1.3)(Krishnamurthy 2006).  
This principle explains why multivalent interactions drive Gibbs free energy of binding to be 
more and more negative (favorable). 
Currently, very few methods currently exist that can  identify a binding pair from its 
native environment (Ilver, 1998) but that method was extremely specific to those conditions, and  
multiple proteins were identified and further knockout experiments were necessary to identify 
the proteins (Ilver 2003).  Identity of necessary binding proteins is typically confirmed through 
gene knockout experiments combined with some assay to study an interaction of interest (Dani 
2012).  Systematic knockouts of genes to identify essential binding proteins is not an effective 
method due to several reasons:  knockouts can be deleterious to the organism, concomitantly 
giving no information about the gene's function; knockouts of similar or identical genes in one 
organism does not produce the same results in another; the background genotype of the organism 
may be responsible for the phenotype and not the induced mutation, causing misinterpretation of 
the results; and the gene may encode for a protein that is involved upstream of the phenotypically 
observed result giving more importance to that gene and ignoring the effects of others involved 
(Gerlai 1996).  If there is some existing evidence that suggests a binding partner, more facile and 
robust methods are available .  They usually require isolated carbohydrate (or a heterogeneous 
carbohydrate mixture) and binding protein with suspected specificity for the presented 
carbohydrate(s)(Chaubard 2012, Liu 2009, Martos-Maldanado 2013).  Typically they require at 
least one of the binding pairs to be homogenous, if not both, and almost all methods cannot 
distinguish the active carbohydrate epitope or peptide responsible for binding from their 
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respective mixtures.  A high throughput method could help narrow potential genes for knockout 
studies if at least one binding partner was discernible from a heterogenic mixture. 
It’s common that following isolation and the subsequent experiments to elucidate 
structure, synthetic methods are often employed to verify the specific binding structure 
(Meloncelli 2011).   These identification experiments take considerable time.  Most of the rapid 
identification techniques used in proteomics or genomics make use of mass spectrometry, but 
due to the isobaric nature of carbohydrates, rapid identification techniques are not currently 
available.  Thus is makes since that most of the known binding experiments frequently use 
purified carbohydrates with attempts to probe protein receptors.   
 
Obtaining Carbohydrates 
 
 Isolation of glycoconjugates from natural sources is a very tedious process that often 
results in relatively small amounts of heterogenic mixtures of glycoconjugates.  As a result, 
subsequent experiments will retain some level of ambiguity in important structure function 
relationships.  There have been efforts in the analytical field to develop reliable methods to 
purify mixtures, but such separations are far from trivialized (Yu 2012).   Well defined chemical 
structures can be obtained by synthetic methods but also suffers from significant challenges.  
 Carbohydrates are linked through glycoside bonds which incorporate the anomeric 
carbon of one monosaccharide with an alcohol of another monosaccharide.  Many carbohydrates 
involved in glycoconjugates have, on average, five hydroxyl groups available for glycosidic 
bond formation, which give rise to five regioisomers possible for any given pair of 
monosaccharides.  The stereochemistry at the anomeric carbon can also vary, further adding 
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complexity to oligosaccharide structure.  Typical synthetic routes to oligosaccharides originate 
from natural monosaccharides, provided they are available and economically feasible, which 
undergo a series of manipulations to protect hydroxyls to exclude them during the glycosylation 
of two monosaccharides.  The synthetic routes can vary depending on monosaccharide and 
desired linkage, but it is not uncommon for 8 or more transformations to be necessary to obtain a 
suitable monosaccharide for glycosylation.   
 
 
Scheme 1.1  Typical glycosylation between a donor and acceptor.  The donor usually has some 
leaving group that can be activated, orthogonally to other protecting groups, that allows for the 
donation of the anomeric carbon to the hydroxyl nucleophile on the acceptor to form a glycosidic 
linkage. 
 
 Glycosylation reactions are also poorly understood; the mechanism of which is actively 
being explored and debated (Scheme 1.1) (Crich 2010).  The typical glycosylation involves a 
pair of monosaccharides, the donor, which donates its anomeric carbon, and the acceptor, which 
bears an alcohol that accepts the anomeric carbon.  The donor usually bears a leaving group that 
can be selectively activated to from a reactive species that will react with a nucleophile to form a 
covalent bond between the nucleophile and the anomeric center of the donor.  The acceptor will 
bear a free hydroxyl group for formation of the glycosidic bond.  Diastereomeric selectivity in a 
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glycosylation reaction is empirically understood and seemingly is dependent upon substrate, 
protecting groups, leaving group, activation conditions, solvent, temperature, and concentration.  
Considerable efforts may be necessary to achieve a desired linkage after preparation of the donor 
or acceptor. 
 Oligosaccharide synthesis is, typically, iterative cycles of glycosylation followed by 
deprotection of a specific hydroxyl on the resulting glycoside that was protected with an 
orthogonal protecting group during the building block preparation.  There are reported methods 
that try to tailor the reactivity of building blocks, through choice of protecting groups, such that 
they can do multiple glycosylation reactions in one pot without need for deprotection (Koeller 
2000, Ye 2000).  Despite the generation of a database through empirical testing of 
monosaccharide donors and acceptors (Zhang 1999, Sears 2001), this method suffers from not 
being able to have enough differentiation in reactivity between many of the acceptors to avoid 
mixtures of products. 
 
Automated Synthesis of Oligosaccharides 
 
 Synthetic challenges due to the complexity of carbohydrate structure have hindered the 
development of automated synthetic methods that have already been successfully and efficiently 
employed for the corresponding biological macromolecules: DNA, RNA, and proteins.  There 
are known examples of solid phase synthesis of oligosaccharides (Ranter 2002), despite the time 
between its initial report, there are very few reports of exploitation of the methodology to access 
novel and interesting carbohydrates.  Typical conditions employing solid phase handles require 
extreme excess of solution reagents to effect complete coupling that overcome the biphasic 
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nature of the reaction.  The preparation of reactive building is extremely limiting in 
oligosaccharide synthesis a contributing factor in the lack of development in solid phase 
approaches for oligosaccharide access.  The optimization of reaction conditions to achieve 
specific linkages in solution does not necessarily translate to solid phase reaction conditions.  As 
previously mentioned, the glycosylation reaction is dependent upon activation conditions, 
concentration, and inherent substrate reactivity.  All of these conditions are hard to control for 
substrates on solid supports.  
 
 
Scheme 1.2  General schematic for an iterative cycle of fluorous tag assisted automation 
solution phase synthesis of oligosaccharides.   
 
 Solution phase automated synthesis has been recently explored as an alternative to 
circumvent the troubles associated with solid phase automated synthesis (Scheme 1.2)(Pohl 
2008).  The method makes use of a perfluorinated alkane as a handle for isolation of synthetic 
intermediates after each couple cycle in the preparation of the oligosaccharide.  This method 
allows for solution phase reaction conditions to translate well to automation as well limiting the 
need of excess donor due to the homogenous reaction conditions.    Automation of carbohydrates 
would propel the field of glycomics forward into a perspective of better understanding of the 
roles of oligosaccharides in biological systems and the molecular basis for those interactions. 
11 
 
 
 Access to this class of biological molecules through automated methods would allow for 
systematic investigation of structure-function relationships and the interactions of these 
molecules in biological systems.   It would also provide a means to construction of carbohydrate 
libraries to probe detailed structure-function relationships. Insights into the basis of these 
molecular functions could aid the development of therapeutics to treat a host of problems that are 
related to oligosaccharide behavior. 
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CHAPTER II 
TRIFUNCTIONAL AFFINITY PROTEOMICS PROBES AS LECTRIN CAPTURE 
REAGENTS 
 
 
Introduction 
 
The roles of many carbohydrates and glycoconjugates in biological systems remain 
ambiguous despite the rapidly developing field of glycomics (Ilver 2003). Glycoconjugates 
found on the surface of cells as abundant as they are diverse, owing that diversity to the innate 
chemistry of oligosaccharides, and exhibit extraordinary binding specificities (Larsson 2000). 
One immensely important function of glycoconjugates is to serve as a signal for many vital 
cellular functions, such as cell-cell recognition. The first essential step to pathogen infection is 
host cell recognition(Ilver 2003, Larsson 2000) which is mediated through the exploitation of 
intimate signal-receptor pairs (Nizet 2009).  Identification of specific cell surface protein-
saccharide pairs involved in such events can provide insight into the mechanism of infection and 
aid the development of therapeutic strategies (Ilver 2003). Herein we report the synthesis of 
trifunctional affinity proteomics probes (TAPPs) for the identification of specific binding 
proteins from protein solutions.   
Efforts have been made towards developing methods to probe protein-saccharide specific 
interactions, but these methods still suffer from limitations that often make them unreliable or 
impractical (Ilver, 2003). For example, a thin layer chromatography (TLC) overlay assay has 
been employed to identify glycolipid binding proteins in bacteria such as Shigella dysenteriae 
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(Lindberg 1987, Soltyk 2002).This assay employs thin layer chromatography to separate a 
heterogeneous mixture of carbohydrates, typically glycolipids, which are then stained with 
radiolabeled bacteria.  This method, however, no longer presents the carbohydrates to binding 
proteins in the multivalent manner typical of cell surfaces (Ilver 2003). The dissociation constant 
(Kd) for monovalent specific interactions is usually in the range of mM whereas the Kd for 
multivalent specific interactions is in the nM range (Houk, 2003).  This million-fold difference in 
binding is the fundamental reason methods such as TLC overlay assay are inadequate for 
detection of interactions dependent on multivalency, which is exemplified in the cases where the 
binding partner escaped detection or was misidentified (Ilver 2003).  A similar assay using gel-
electrophoresis to separate glycoproteins has been explored but faces many more shortcomings.  
Glycoproteins, unlike glycolipids, have a diverse set of glycosides per molecule.  Thus, the exact 
identification of the carbohydrate is impossible without further fractionations and assays (Ilver 
2003).  Not only does this method suffer from being a lengthy procedure, once fractionated, loss 
of multivalency occurs, allowing binding partners to evade detection.  An affinity tag approach 
has been used to capture lectins (Ilver 1998) and improved upon with a bottom-up affinity 
proteomics approach (Larsson 2000) to identify binding proteins.  This method use a bovine 
serum albumin (BSA) core that has been covalently modified with oligosaccharides and a 
photoactivated cross linking reagent, therefore circumventing the multivalency issue, but still has 
its limitations.  The protocols for preparing and employing the conjugated BSA core are not 
general enough to be efficient for the continual increase of new pathogen targets (Ilver 2003).  
Lectins are often found in low abundance and after the tagging require streptavidin enrichment 
prior to separation using gel electrophoresis.  Adhesins are often membrane or pilus bound and 
do not typically resolve well with gel-electrophoresis (Ilver 2003). More recent efforts to solve 
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these problems have been reported, but have yet to show diverse utility.  One method involves 
using modified biological pathways to incorporate derivatives of carbohydrates to capture 
binding proteins in vivo (Yu 2012). Another employs photosensitizing nanoparticles conjugated 
with a purified saccharide and protein of interest (Chang 2011).  These methods present 
significant constraints to throughput in detecting bacterial adhesins or lectins.  The former 
method involves modifying molecular pathways to tolerate non-canonical saccharides and 
presumes the saccharide modification will not inhibit receptor recognition.  The latter method 
requires purified saccharides and protein receptors, and would not be directly applicable to 
capturing unknown membrane-bound binding partners.  A more versatile carrier capable of being 
applied to pilus and membrane bound adhesins coupled with the bottom-up proteomics detection 
would be a very powerful lectin capture reagent.  
 
Results and Discussion 
 
 To achieve the goal of identifying carbohydrate-binding proteins with greater fidelity, 
ideally a trifunctional affinity proteomics probe would need to be employed (Figure 2.1).  To 
meet the requirement of a bottom up proteomics approach a handle is required to purify captured 
proteins.  A solid phase resin confers the necessary properties to support such a general and 
flexible lectin capture reagent.   
The development of rinsing protocols that inhibit nonspecific interactions while leaving 
specific interactions intact can be tedious and irreproducible, thus if a covalent bond can be 
formed between the solid support and the binding protein, very stringent, denaturing, and 
reproducible washing conditions are needed to remove matrix proteins without concern of losing 
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binding proteins.  This can be achieved by using one of the many known protein cross-linking 
reagents in literature (Sinz 2006).  Finally, the carbohydrate signal that is being used to probe for 
receptors is the third functionality.     
 
 
 
Figure 2.1  Conceptual design of a trifunctional affinity proteomics probe (TAPP) to capture 
lectins and adhesins 
 
With this model in mind, two probes were devised, one bearing α-D-mannose (1) and the 
other β-D-galactose (2), intended to be used as positive and negative controls, respectively, in a 
simple model system to test the basic principle (Figure 2.2a).  For characterization puprposes, the 
resin coupling will be the final step, which would make benzoic acids 3 and 4 the penultimate 
targets for 1 and 2, respectively. 
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Figure 2.2 (a) Molecular design of TAPPs and (b) retrosynthetic analysis.    
 
The two excitation maxima, of which the higher energy maxima is hypothesized to excite the 
probe to an intermediate that does not form cross-links adducts (Buchmueller 2003).  To simplify 
characterization data of the probe, the central tethering moiety was chosen to be 3,5-
diaminobenzoic acid (7), which allows for three unique branches to be coupled without creating 
regio- or stereoisomers, as well as being economically effective and providing convenient 
handles for peptide coupling chemistry.  The amide linkages were exploited for coupling the 
three functional moieties together as the amide is a robust functional group and the final probe 
would then mimic proteins and be suitable for the aqueous experimental conditions.  
17 
 
 
Retrosynthetic analysis of TAPPs leads to a convergent synthesis (Figure 2.2b) in which the 
saccharide coupling conditions can be effected as late in the synthetic scheme as possible to 
make it as general as possible as well as be amenable to combinatorial chemical methods. 
Synthesis of the aryl azide branch started with the well known para-azidobenzoic acid 10 
(Pinney 1991). The acid was converted to the activated acyl chloride with phosphorus 
pentachloride in anhydrous diethyl ether, the product of which was immediately subjected to a 
solution of β-alanine in 1N NaOH(aq) which afforded 5 in good yield.  The carboxy methyl 
glycosides 8 (Cheaib 2008) and 9 (Listkowski 2007) are known compounds and were prepared 
as reported.  Preparation of the amine terminated polystyrene resin was achieved with standard 
peptide coupling reagents, namely diispropylcarbodiimide (DIC) and ethylene diamine in N,N-
dimethylformamide. To ensure good loading, the resin was again subjected to the reaction 
conditions.  Verification of functional group transformation was done with Kaiser’s test (Kaiser 
1970) which resulted in a deep blue resin indicative of a successful coupling of the diamine to 
give the amine terminal resin (6), considered to be the result of the formation of a Schiff base 
between the reagents and the amine functionality on the surface of the resin.   
aforementioned saccharides were used in order to take advantage of well known interactions of 
α-D-mannose with plant.  lectin concanavalin A from C. ensiformis and the bacterial adhesin, 
FimH, expressed by E. coli (Summer 1938).  The cross-linking reagent used for this set of 
experiments belongs to a well studied class of photoactivated cross-linkers: aryl azides 
(Buchmueller 2003).  The para-substituted phenylazide (5) was employed for its low cost and 
ease of synthetic preparation.  A commercially available carboxy-modified polystyrene (6) solid 
support was utilized as it offers general coupling conditions, good loading capacity, and, 
critically, low wavelength protection of the photo cross-linker.  Aryl azides are known to exhibit  
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Scheme 2.1  Preparation of the three functional moieties of the TAPP reagents. 
 
With all three functional moieties in hand, exploration of coupling conditions originated 
from the known ethyl 5-amino-2-(t-butoxycarbonyl)aminobenzoate 12 (Ishida 2001).  The 
preparation of 13 was achieved in a slightly modified procedure than the reported method.  Ester 
formation was accomplished with commercially available 7 and 3 eq. of conc. sulphuric acid in 
anhydrous ethanol (Scheme 2.2) to give diamine 11.  Selective mono-protection of 12 was 
achieved with di-tert-butyl-dicarbonate in methylene chloride in the presence of triethylamine to 
afford carbamate 12.   Peptide coupling reagents were explored to effect the formation of the 
desired amide bond.  Initial efforts using DIC or 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(EDC) were unsuccessful (Table 2.1).  Additives, such as N’,N’-dimethylaminopyridine 
(DMAP), are known to enhance the reactivity of the intermediate complex, but DMAP was 
ineffective in increasing the reactivity.  Activation with N-hydroxybenzotriazole successfully 
completed the transformation to the desired amide 13.  However, later in the course of the 
project, these conditions were abandoned for 2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl 
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uranium hexafluorophosphate (HATU), which was able to perform the transformation in a 
considerably shorter reaction time. 
 
Scheme 2.2  Synthetic strategy for the TAPP scaffold.    
 
Table 2.1  Explored coupling conditions. 
 
Entry 
Coupling 
Reagent 
Additive 
Time 
(hr) 
Temperature 
(°C) 
Yielda 
(%) 
1 DIC DMAP >96 25 N/A 
2 DIC DMAP >96 60 N/A 
3 EDC HOBt 96 25 95 
4 HATU - 60 25 92 
5 HATU - 40 40 96 
  aN/A indicates no isolated product 13.   
 
Acid-mediated cleavage of the boc carbamate protecting using trifluoroacetic acid (TFA) 
and subsequent basic work up afforded amine 14 in good yield (Scheme 2.3).  The previous 
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peptide coupling conditions were again employed for each of the carboxy methyl glycosides, α-
D-mannoside 8 and β-D-galactoside 9, to furnish the protected probes 15 and 16, respectively, in 
good yields.   The deprotected acids 3 and 4 were obtained by global hydrolysis of the ester 
protecting groups using saturated aqueous potassium carbonate and methanol.  Solid phase 
functionalization was affected in two 24-hour coupling cycles, each using five equivalents of 
probe relative to the carboxylate sites on the resin and HATU in DMF.   The extent of coupling 
was probed using the phenol sulphuric acid assay (Table 2.2) (Dubois 1956). 
 
 
Scheme 2.3   Final synthetic procedure for TAPP-HMan and TAPP-HGal. 
Cross-linking experiments were performed in glass test-tubes pre-treated with BSA to 
minimize interactions of ConA with the test tubes’ glass surface (Varmette, 2010).  One 
milligram of probe was suspended in PBS buffer.  The test tubes were incubated for 16 hours in  
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Table 2.2  Extent of resin loading. 
Probe Loading (µg probe/mg resin) Error (µg probe/mg resin) 
TAPP-HMan 70 3 
TAPP-HGal  44 1 
TAPP-FMan 52 1 
TAPP-FGal 63 1 
  
the dark.  They were then irradiated with a 350 nm broadband source for 2 hours at 37 °C.  The 
probes were then rinsed with a series of solutions of an aqueous DMSO gradient, three cycles 
each (10, 25, 50, 75% aq. DMSO).  Each cycle consisting of vortexing with the rinsing solution 
then centrifugation at 12,000 RPM for 10 minutes followed by removing the supernatant.  The 
resins were finally rinsed with pure DI water three times to remove any DMSO before the tryptic 
digest.  The resulting peptide mixtures were then analyzed with MALDI-QTOF.  The results 
from the MASCOT database search of the MS/MS data resulted in scores well above the 95% 
confidence level for the presence of ConA captured by both probes (Perkins 1999) (Appendix 
D).  Initial results would suggest one of two things: either the employed analysis was not 
adequate for detecting the discrepancy in specific and non-specific interactions or the underlying 
chemistry in the capturing probe was not selective enough. 
Fluorinated probes have shown to be more useful in such applications due to their difference 
in photochemistry (Schnapp 1993).  The singlet nitrene lifetime in perfluorinated probes are 
sufficiently longer to form C-H insertion products that give rise to more useful cross-links 
relative to the reactive ketenimine of the parent aryl azide.  To further improve upon the initial 
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experiments, relative quantification methods should be employed to provide objective definition 
between specific and non-specific interactions (Zhu 2010).  
Preparation of the fluorinated probes originated from the known NHS ester 17 (Norberg 
2009).  Displacement of the NSH ester with β-alanine was achieved in aqueous triethylamine 
(Scheme 2.4) with high yield of amide 18.  Synthesis of the fluorinated probes mimicked the 
parent aryl azide without any complications.  After obtaining 23 and 24, coupling to the resin 
was done with HATU to produce the final resin bound TAPP-FMan, 25, and TAPP-FGal, 26 
(Scheme 2.5).  The extent of loading for each probe was quantified with the phenol sulphuric 
acid assay (Table 2.2).   
 
Scheme 2.4  Synthesis of the fluorinated TAPPs 
 
All four probes were subjected to the same incubation, cross-linking, rinsing, and digest 
protocol as described earlier.  An aliquot of the samples obtained from the tryptic digestion were 
subjected to nano-LC ESI-Ion Trap.  The obtained MS/MS spectra were analyzed using a 
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MASCOT database search.  Several fragments were matched as belonging to the parent protein, 
concanavalin A from C. ensiformis.  The peptide chosen for relative quantification using the 
extracted ion chromatogram (EIC) was selected due to its ubiquitous nature.  The extracted ion 
chromatogram was obtained by using Thermo Scientific Xcalibur and extracting the 
chromatogram to a range ± 0.5 Da from the experimentally determined M/Z corresponding to 
ubiquitously matched fragment with sequence VGLSASTGLYK.   
 
 
Scheme 2.5   Coupling of probes to solid phase resin. 
 
The retention times were validated comparing the MASCOT database search matched peak 
list for the fragment to the individual MS/MS spectra obtained at given retention times and are in 
good agreement (Table 2.3).  The EIC was then integrated over the area in which the parent ion’s 
signal to noise ratio was at least 3:1 (Table 2.4) (Appendix C).  The peak areas were normalized 
by dividing the peak area by the largest peak area in the data set.   
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Table 2.3  Retention times (Min.) for peptide fragment VGLSASTGLYK for each sample.   
Probe 123 nmol 24.6 nmol 12.3 nmol 2.5 nmol 
TAPP-HMan 16.08 16.03 16.13 N/A 
TAPP-HGal 16.01 16.00 16.01 N/A 
TAPP-FMan 16.13 15.88 16.04 16.09 
TAPP-FGal 16.10 16.16 16.19 N/A 
   
 
Table 2.4  Normalized peak areas of the extracted ion chromatogram for the mass ±0.5 Da 
corresponding to matched peptide VGLSASTGLYK.   
Probe 123 nmol 24.6 nmol 12.3 nmol 2.5 nmol 
TAPP-HMan 0.35 ± 0.02 0.30 ± 0.01 0.10 ± 0.04 N/A 
TAPP-HGal 0.17 ± 0.04 0.09 ± 0.01 0.04 ± 0.01 N/A 
TAPP-FMan 1.00 ± 0.03 0.55 ± 0.01 0.38 ± 0.03 0.07 ± 0.03 
TAPP-FGal 0.17 ± 0.03 0.12 ± 0.01 0.07 ± 0.01 N/A 
   
 
The signal to noise ratio in the case of the minimal amount of probe used in the tryptic digest 
for TAPP-HMan, TAPP-HGal, and TAPP-FGal was so low for the matched peptide, no 
discernible peaks for integration were able to be identified from the background with confidence.  
The normalized peak areas suggest the fluorinated aryl azide out performs the parent aryl azide 
in selectivity, in all cases exhibiting a 5:1 ratio in peak area for the positive control to the  
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Figure 2.3  Normalized peak areas for TAPP probes are various amounts of resin used for the 
experiment.  
 
negative control.  The discrepancy between the positive and negative controls for the parent aryl 
azide for the maximum subjected probe was 3:2 and in the best case 9:2 for sample 3.  The 
sensitivity difference is apparent as the only probe to give quantifiable signal for the matched 
peptide is TAPP-FMan at the lowest subjected probe amount.  
Although no modeling was done to ensure capture by the probe is possible while con A was 
bound, the probe and carbohydrate had relatively similar linker length thus it seems reasonable 
that it is indeed possible.  The difference in captured protein amounts should not be dependent on 
the probe if it were not involved.  The results suggest the captured protein is dependent upon the 
probe chemistry, making it logical to implicate the photo probe in being intimately involved in 
capturing the protein.   
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Conclusion 
 
 A solid phase platform was successfully able to capture lectin capture reagents in a 
selective manner for positive and  negative controls.  The method was shown to be sensitive and 
efficient with costly materials, needing only 100 nm of probe to obtain useful data, which can be 
achieved with 1 µmol of material.  Trypsin was shown to be able to cleave proteins off the 
surface of the resin in adequate amounts for several nano-LC-ESI MS/MS runs for the case of 
con A.  Such an experiment produces data that can be analyzed with existing tools to extract 
relative peptide concentrations across the samples. 
 The perfluorinated aryl azide probes were shown to have greater efficiency and 
selectivity for capturing specific interactions relative to probes with the parent aryl azide.  One 
limitation of this method is that the proteins are only able to be relatively quantified across 
samples and thus, one negative control would always be necessary to put the interaction of 
interest in perspective.  Sstudies involving multiple signals for comparison could prove to help 
define a specific interaction  much like work with microarrays (Smith 2013). 
 The utility of this method is highly dependent on the ability to directly capture surface 
binding proteins.  Combined with combinatorial chemical methods for carbohydrate production, 
it would certainly create a versatile and facile tool for identification of host and pathogen 
interactions. 
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Experimental 
 
General: All commercially available compounds were purchased from TCI, Sigma Aldrich, or 
Fisher Scientific; they were reagent grade and used without further purification.  HATU was 
purchased from  Accela  ChemBio.  For sensitive reactions, solvents were dried prior to use by 
distillation from a suitable drying agent.  Column chromatography was performed with ZEOprep 
ECO silica gel 60 with 40-63 µm particle size (American International Chemical).  Reactions 
were monitored using thin layer chromatography coated with a 0.25 mm layer of silica gel 60 
F254 (Sorbent Technologies).  Compounds were visualized with UV light and/or 5% v:v sulfuric 
acid in ethanol.  1H NMR and 13C NMR were performed with either a Bruker Avance DRX-400 
MHz spectrometer or a Varian VXR-400 MHz spectrometer, or otherwise noted.  All 1H NMR 
peak assignments were made using solvent residual peaks as an internal standard (DMSO δ 2.50 
ppm, CDCl3 δ 7.26 ppm, and CD3OD δ 3.31) as were 13C NMR peak assignments (DMSO δ 
39.51 ppm, CDCl3 δ 77.31 ppm, and CD3OD δ 49.00) and supported using 1H-1H COSY 
experiments as needed.   High resolution mass spectra were obtained with a Finnigan TSQ700 
for compound characterization.  Mass spectroscopy data for protein identification was obtained 
with a Thermo Scientific LTQ Velos Pro, a nano-LC-ESI ion trap instrument.   
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3-(4-azidobenzamido)propanoic acid (5): To a solution of p-azidobenzoic acid (2.06g, 
12.6 mmol) in diethyl ether (60 mL) was added Phosphorus Pentachloride (2.68g, 12.9 mmol) 
and let stir for 1 hour.  The ether was removed in vacuo to yield a yellow residue which was 
triturated with hexanes at 0° C to yield a pale yellow solid which was used directly in the next 
step.  To a solution of β-alanine (1.00 g, 11.26 mmol) in 1 N NaOH (23 mL) was added p-
azidobenzoyl chloride (1.13 g, 6.62 mmol) at 0 °C.  The solution was let stir for one hour then 
removed from the ice bath and let warm slowly to room temp (2 hours).  The reaction was 
brought to pH 3 using 1 N HCl in which a white precipitate formed.  The solid was filtered and 
recrystallized from ethanol to yield 5 as a pale yellow needles (0.97 g, 67% over 2 steps).  
 
1H NMR (DMSO, 400 MHz): δ 8.54 (1H, t, J = 4.8 Hz, HN), 7.88 (2H, d, J = 8.4 Hz, HAr), 7.19 
(2H, d, J = 8.8 Hz, HAr), 3.47-3.42 (2H, m, H2), 2.51 (2H, t, J = 7 Hz, H1).  
 
13C NMR (DMSO, 400 MHz): δ 33.75, 35.60, 118.89 (x2), 129.07 (x2), 130.90, 142.24, 156.25, 
172.92.  
 
HRMS Calcd for [M+H]+. 235.0825 Found: 235.0820. 
 
 
Ethyl 3,5-Diaminobenzoate(11): To a solution of 3,5-Diaminobenzoic Acid (7.64 g, 50.21 
mmol) in 200 proof Ethanol (300 ml) was added conc. Sulfuric Acid (8.37 mL, 150.6 mmol).  
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The reaction was refluxed for 24 hrs.  The ethanol was removed in vacuo. Iced cold water was 
added (75 mL) to the residue and made slightly alkaline with the addition of solid sodium 
carbonate.  The aqueous layer was extracted with ethyl acetate (4x100 mL), washed with sodium 
bicarbonate (3x250mL), water (3x250mL), and dried over sodium sulfate.  The ethyl acetate was 
removed in vacuo to yield a dark amber residue.  The residue was purified by column 
chromatography (EtOAc:Hexane, 1:1) to yield an amber residue (7.59 g, 84%).  NMR Matched 
previously reported spectra (Ishida 2001). 
 
 
Ethyl  5-amino-3-(t-butoxycarbonyl)aminobenzoate(12): To a solution of Ethyl 3,5-
Diaminobenzoate (5.02 g, 5.66 mmol) and Diisopropylethyl Amine (2.5 mL, 15.1 mmol) in 
Dichloromethane at 0° C was added Ditertbutyldicarbonate (1.24 g, 5.68mmol) in 20 ml 
dichloromethane dropwise over 30 minutes.  The reaction was let stir for 8 hours at room 
temperature and the solvent was removed in vacuo to yield a brown residue.  The mono 
protected compound was obtained with flash chromatography (EtOAc:Hexane 1:1.  The resulting 
fractions were pooled and concentrated in vacuo to yield a yellow oil which was triturated with 
hexanes to afford a white solid.  The hexane was filtered off and the compound was dried under 
high vacuum to yield a white powder (0.932g, 74%).  NMR Matched previously reported spectra 
(Ishida 2001). 
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Ethyl  3-(tbutoxycarbonyl)amino-5-(3-(4-azidobenamido) 
propanamidobenzoate(13): To a solution of 5 (2.19g, 9.37 mmol), 12 (2.63 g, 9.37 mmol), 
and HATU (3.92 g, 10.3 mmol) in DMF (20 mL)  was added triethylamine (2.61 mL, 18.7 
mmol)  The reaction was warmed to 40 °C for 40 hours.  The reaction was quenched by the 
addition of water (100 ml).  Ethyl acetate (50 ml) was added and the reaction was let stir 
vigorously for 10 minutes.  The layers were separated and the aqueous layer was extracted with 
ethyl acetate (3x100 ml) and the combined organic layer was washed with sat. sodium 
bicarbonate (3 x 300 ml), water (3 x 300 mL) and dried over sodium sulfate.  The solvent was 
removed in vacuo and the crude product was recrystallized with a mixture of ethyl acetate and 
hexanes to furnish 13 (4.44 g, 8.94 mmol, 96%) as a white solid.  
 
1H NMR (DMSO, 400 MHz): δ 10.17 (1H, s, HNH-Ar), 9.61 (1H, s, Hcarbamate), 8.63 (1H, t, J = 4 
Hz, HNH-alk), 8.02 (1H, s, HAr), 7.96 (1H, s, HAr), 7.89 (2H, d, J = 12 Hz, HAr), 7.74 (1H, s, HAr), 
7.19 (2H, d, J = 12 Hz, HAr), 4.29 (2H, q, J = 8 Hz, HOCH2), 3.57-3.50 (2H, m, HCH2), 2.61 (2H, t, 
J = 8 Hz, HCH2CON), 1.47 (9H, s, HtBu), 1.30 (3H, t, J = 8 Hz, HCH3).   
 
13C NMR (DMSO, 100 MHz): 172.49, 169.45, 167.84, 155.16, 145.05, 141.66, 140.64, 132.69, 
132.21, 130.36 (x2), 120.14 (x2), 116.34, 115.74, 81.30, 62.41, 42.84, 37.65, 28.81 (x3), 23.68, 
14.74.  
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HRMS Calcd for [M+H]+ 497.2143 Found: 497.2147. 
 
 
Ethyl 5-amino-3-(3-(4-azidobenzamido)propanamido)benzoate(14): To 13 (4.19 g, 
8.44 mmol) was added 1:1(v:v) mixture of methylene chloride and trifluoroacetic acid (20  ml).  
The reaction was let stir for 10 minutes at room temperature.  The solvent was removed in vacuo.  
Iced water (20  ml) was added to the crude product and made slightly alkaline with the addition 
of sodium carbonate.  The mixture was diluted with 200 ml DI water and the aqueous layer was 
extracted with ethyl acetate (3x 150 ml) and the combined organic layers were washed with 
sodium bicarbonate (3 x  400 ml), water (3 x 400 ml), and dried over sodium sulfate.  The 
solvent was removed in vacuo and the crude product was recrystallized from an ethyl acetate and 
hexanes mixture to afford compound 14 (2.75 g, 6.94 mmol, 82%) as a light tan amorphous 
solid.  
 
1H NMR (DMSO, 400 MHz): δ 9.87 (1H, s, HNH), 8.60 (1H, t, J = 5.4 Hz, HN'H), 7.89 (2H, d, J = 
8.4 Hz, HAr), 7.34 (1H, s, HAr).  
 
 13C  NMR (DMSO, 100 MHz) δ 169.69, 165.57, 165.30, 152.68, 142.16, 140.13, 139.71, 
131.00, 130.45, 129.05, 118.84, 113.58, 113.03, 79.30, 60.72, 36.27, 35.88, 28.07, 14.18.   
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HRMS Calcd for [M+H]+: 397.1619 Found: 397.1612. 
 
 
3-(4-azido-2,3,5,6-tetrafluorobenzamido)propanoic acid(18): To a solution of β-
alanine(0.644 g, 7.23 mmol) in DI water (5 ml) at 0 °C was added TEA (1.1 ml, 7.83 mmol)) 
was added 17 (2.00 g, 6.02 mmol).  The reaction was let stir for 1 hr at 0 °C and then let warm 
up to room temperature and stirred 16 hours at rt.  The reaction was acidified to pH 3 with dilute 
HCl(aq).  The crude precipitate was filtered and recrystallized with a mixture of chloroform and 
hexane to yield a white, amorphous solid (1.60 g, 5.23 mmol, 87%).   
 
1H NMR (500 MHz, cdcl3) δ 6.58 (s, 1H), 3.74 (dd, J = 11.5, 5.7 Hz, 2H), 2.75 (dd, J = 10.8, 5.1 
Hz, 2H).   
 
13C NMR (100 MHz, CDCl3) δ 170.54, 166.33, 158.05, 152.87, 139.60, 139.29, 131.64, 115.25, 
115.03, 114.13, 80.76, 61.29.   
 
HRMS Calcd for [M+Na]+: 329.0268 Found: 329.0272. 
 
33 
 
 
 
Ethyl  3-(t-butoxycarbonyl)amino-5-(3-(4-azido-2.3.5.6-tetrafluorobenzamido) 
propanamido)benzoate(19): To solution of 18 (1.58 g, 5.16 mmol) in , Ethyl  5-amino-3-(t-
butoxycarbonyl)aminobenzoate (1.80 g, 5.67 mmol) and HATU (2.14 g, 5.67 mmol) in DMF (10 
ml) under an inert atmosphere was added DIPEA (1.8 ml, 10.4 mmol).  The reaction was let stir 
at room temperature for 60 hours.  The reaction was quenched with DI water and extracted 3x75 
ml Ethyl Acetate and the combined organic layer was washed 3x250 ml sat. NaHCO3 and 3x250 
ml DI water.  The solvent was dried over Na2CO3 and then removed in vacuo.  The crude 
product was recrystallized from a mixture of methylene chloride and hexane.  
 
1H NMR (400 MHz, CD3OD) δ 7.47 (t, J = 1.6 Hz, 1H), 7.26 (t, J = 2.0 Hz, 1H), 7.14 – 6.96 (m, 
1H), 5.52 (s, 2H), 4.31 (q, J = 7.1 Hz, 2H), 3.71 (t, J = 6.6 Hz, 2H), 2.71 (t, J = 6.7 Hz, 2H), 1.36 
(t, J = 7.1 Hz, 3H). 
 
HRMS Calcd for [M+Na]+:  519.1962 Found: 519.1968. 
 
Ethyl  5- amino-3-(3-(4-azido-2.3.5.6-tetrafluorobenzamido)propanamido) 
benzoate(20): 
To 13 (4.19 g, 8.44 mmol) was added 1:1(v:v) mixture of methylene chloride and trifluoroacetic 
acid (20  ml).  The reaction was let stir for 10 minutes at room temperature.  The solvent was 
removed in vacuo.  Iced water (20  ml) was added to the crude product and made slightly 
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alkaline with the addition of sodium carbonate.  The mixture was diluted with 200 ml DI water 
and the aqueous layer was extracted with ethyl acetate (3x 150 ml) and the combined organic 
layers were washed with sodium bicarbonate (3 x  400 ml), water (3 x 400 ml), and dried over 
sodium sulfate.  The solvent was removed in vacuo and the crude product was recrystallized 
from an chloroform and hexanes mixture to afford compound 14 (2.75 g, 6.94 mmol, 82%) as a 
light tan amorphous solid.  
 
1H NMR (400 MHz, DMSO) δ 10.84 (s, 1H), 7.34 (s, 1H), 7.23 (s, 1H), 6.99 (s, 1H), 5.57 (s, 
2H), 4.26 (q, J = 7.1 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H).   
 
HRMS Calcd for[M+H]+: 469.1241Found 469.1247. 
 
General procedure for HATU mediated carboxymethyl glycoside and probe 
coupling:  To aminoprobe (14 or 20) (1 eq.), carbohydrate (8 or 9) (1.2 eq), and HATU (1.2 eq) 
in a dry round bottom under an inert atmosphere was added DMF (5 ml) and DIPEA (2 eq).  The 
reaction was stirred at room temperature for 60 hours or at 40 °C for 40 hours.  The reaction was 
quenched with addition of 20 50 ml DI water and extracted 3x50 ml Ethyl Acetate.  The 
combined organic layer was washed 3x200 ml DI Water and 2x200 ml Brine.  The Organic layer 
was dried over Na2SO4 and the solvent was removed in vacuo.  The crude product was purified 
by column chromatography, (MeOH/Me2CO/CH2Cl2 1:20:79).   
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Ethyl 3-((4-azidobenzamido)propanamido)-5-(1-O-(2,3,4,6-tetra-O-acetyl-α-D-
mannosyl)acetamido)benzoate(15):  Compound 14 (1.00 g, 2.52 mmol) and 8 (1.23 g, 3.03 
mmol) were coupled using the general coupling conditions described above to afford compound 
15 (1.57 g, 1.97 mmol, 78%) as a pale yellow syrup.   
 
1H NMR (400 MHz, CDCl3) δ 8.26 (s, 1H), 8.03 – 7.94 (m, 3H), 7.90 (s, 1H), 7.81 (d, J = 8.8 
Hz, 2H), 7.18 (t, J = 6.3 Hz, 1H), 7.04 (d, J = 8.8 Hz, 2H), 5.46 (ddd, J = 13.3, 6.6, 2.6 Hz, 2H), 
5.33 (t, J = 9.9 Hz, 1H), 4.98 (d, J = 1.8 Hz, 1H), 4.44 – 4.26 (m, 4H), 4.21 – 4.12 (m, 2H), 4.08 
– 4.00 (m, 1H), 3.92 – 3.80 (m, 2H), 2.76 (t, J = 5.7 Hz, 2H), 2.19 (s, 3H), 2.11 (s, 3H), 2.07 (s, 
3H), 2.05 (s, 3H), 1.39 (t, J = 7.1 Hz, 3H).   
 
13C NMR (100 MHz, CD3OD) δ 169.74, 167.94, 167.01, 165.33, 142.20, 139.58, 138.81, 
131.43, 130.99, 129.07, 118.88, 115.45, 115.24, 114.36, 99.89, 74.49, 77.07, 69.82, 66.93, 65.29, 
61.17, 36.32, 35.92.   
 
HRMS Calcd for [M+H]+: 785.2624 Found: 785.2632 
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Ethyl 3-((4-azidobenzamido)propanamido)-5-(1-O-(2,3,4,6-tetra-O-acetyl-β-D-
galactosyl)acetamido)benzoate(16):  Compound 14 (530 mg, 1.3 mmol) and 9 (636 mg, 
1.6 mmol) were coupled with the general procedure above.  After column chromatography,16 
(854 mg, 1.09 mmol, 83%) was obtained as a pale yellow syrup.  
 
1H NMR (400 MHz, CDCl3) δ 8.53 (s, 1H), 8.26 (s, 1H), 7.97 (s, 1H), 7.91 (s, 1H), 7.80 (d, J = 
8.7 Hz, 2H), 7.57 (s, 1H), 7.07 (dd, J = 15.6, 6.9 Hz, 3H), 5.44 (d, J = 2.8 Hz, 1H), 5.32 (dd, J = 
10.5, 7.8 Hz, 1H), 5.09 (dd, J = 10.6, 3.4 Hz, 1H), 4.59 (d, J = 7.9 Hz, 1H), 4.44 (d, J = 15.2 Hz, 
1H), 4.38 (q, J = 7.1 Hz, 2H), 4.17 (t, J = 6.9 Hz, 2H), 3.99 (t, J = 6.2 Hz, 1H), 3.89 – 3.76 (m, 
2H), 2.74 (t, J = 5.5 Hz, 2H), 2.21 (s, 3H), 2.13 (s, 3H), 2.03 (s, 3H), 1.98 (s, 3H), 1.39 (t, J = 7.1 
Hz, 4H).   
 
13C NMR (100 MHz, CDCl3) δ 207.10, 206.86, 206.52,172,71, 172.36, 171.52, 155.66, 155.55, 
151.34, 151.24, 137.81, 137.61, 129.12, 128.23, 126.54, 126.46, 119.22, 119.17, 114.54, 102.74, 
101.08, 100.99, 100.95, 77.55, 77.23, 76.91, 71.67, 69.01, 68.29, 66.54, 55.70, 38.11, 37.85, 
29.80, 29.74, 28.30, 28.24, 27.96.   
 
HRMS Calcd for [M+H]+: 785.2624 Found: 785.2632 
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Ethyl 3-((4-azido-2,3,5,6-tetrafluorobenzamido)propanamido)-5-(1-O-(2,3,4,6-tetra-
O-acetyl-α-D-mannosyl)acetamido)benzoate(21):  Compound 20 (355 mg, 0.76 mmol) 
and 8 (370  mg, 0.91 mmol) were coupled using the general procedure above to provide 21 (443 
mg, 0.52 mmol, 68%).  
 
 1H NMR (400 MHz, CDCl3) δ 8.40 (s, 1H), 8.18 (s, 2H), 8.05 (s,1H), 7.94 (s, 1H), 6.51 (s, 1H), 
5.42-5.40 (m, 2H) , 5.34- 5.32 (m, 2H), 4.97 (s, 1H), 4.37-4.29 (m, 4H), 4.25-4.03 (m, 3H), 3.81 
(s, 4H), 2.19 (s, 3H), 2.11 (s, 3H), 2.07 (s, 3H), 2.04 (s, 3H), 1.39 (t, 3H, J = 6.8 Hz).   
 
13C NMR (150 MHz, CDCl3) δ 171.05, 170.90, 170.53, 170.38, 169.86, 167.36, 166.92, 166.03, 
143.57, 138.82, 137.57, 131.65, 130.82, 129.14, 119.11, 117.78, 117.41, 116.55, 98.29, 69.53, 
69.36, 69.22, 67.33, 66.00, 62.45, 61.57, 36.90, 36.51, 21.06, 20.96, 20.94, 20.89, 14.44. 
 
HRMS Calcd for [M+Na]+ : 879.2067 Found: 879.2070 
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Ethyl 3-((4-azido-2,3,5,6-tetrafluorobenzamido)propanamido)-5-(1-O-(2,3,4,6-tetra-
O-acetyl-β-D-galactosyl)acetamido)benzoate(22):  Compound 20 (575 mg, 1.23 mmol) 
and 9 (599 mg, 1.47 mmol) were coupled using the general procedure above to provide 22 (771 
mg, 0.90 mmol, 73%).   
 
1H NMR (400 MHz, cdcl3) δ 8.55 (s, 1H), 8.28 (s, 1H), 7.97 (s, 1H), 7.85 (s, 1H), 7.67 (s, 1H), 
7.09 (s, 1H), 5.44 (d, J = 3.0 Hz, 1H), 5.32 (dd, J = 10.5, 7.9 Hz, 1H), 5.09 (dd, J = 10.6, 3.3 Hz, 
1H), 4.59 (d, J = 7.8 Hz, 1H), 4.45 – 4.34 (m, 3H), 4.25 (d, J = 15.3 Hz, 1H), 4.20 – 4.11 (m, 
2H), 3.98 (t, J = 6.5 Hz, 1H), 3.80 (d, J = 5.7 Hz, 2H), 2.74 (s, 2H), 2.21 (s, 3H), 2.13 (s, 3H), 
2.03 (s, 4H), 1.95 (s, 3H), 1.39 (t, J = 7.1 Hz, 3H).  
 
 13C NMR (150 MHz, CDCl3) δ 170.96, 170.70, 170.65, 170.44, 170.27, 167.17, 167.15, 166.10, 
143.60, 139.33, 138.06, 132.08, 130.92, 129.14, 119.19, 117.08, 116.49, 115.48, 101.71, 71.39, 
70.49, 69.46, 67.07, 61.63, 61.53, 38.87, 36.83, 36.26, 31.19, 21.22, 20.89, 20.82, 14.52.   
 
HRMS Calcd for [M+Na]+ : 879.2067 Found: 879.2070. 
 
General procedure for the hydrolysis of ester protecting groups 
To protected probe (16, 17, 21, or 22) was added equal parts methanol and sat. K2CO3(aq.) to 
make a final concentration of 0.1M probe.   The reaction was let stir at room temperature for 12 
hours.  Two ml methanol was added to the reaction, and the potassium acetate was removed by 
filtration.  The filtrate was acidified with DOWEX 50WX8 acidic resin to pH 3.  The resin was 
filtered and rinsed with generous portions of methanol.  The solvent was removed in vacuo to 
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afford crude products (3, 4, 5 or 6).  Probes  5 and 6 were used without further purification.  
Products 3 and 4 were triturated with 0.5 ml DI water and obtained as a white solid after 
filtration. 
 
3-((4-azidobenzamido)propanamido)-5-((1O-α-D-mannosyl)acetamido)benzoic 
acid(3): Compound  15 (615 mg, 0.784 mmol) was deprotected according to the general 
procedure.  The crude product was triturated with water to yield 3 as a white amorphous solid 
(425 mg, .723 mmol, 92%).   
 
1H NMR (DMSO, 400 MHz): δ 12.94 (1H, s, H-CO2H), 10.19 (1H, s, H-NHamide), 9.97 (1H, s, 
H-NHamide), 8.62 (1H, t, J = 5.4 Hz, H-NHamide), 8.21 (1H, s, H-Ar), 7.98 (1H, s, H-Ar), 7.90 (1H, 
s, H-Ar), 7.89 (2H, d, J = 8.4 Hz, H-Ar), 7.19 (2H, d, J = 8.8 Hz, H-Ar), 4.82 (2H, d, J = 4.4 Hz, 
H-OHd), 4.75 (1H, s, H-Hα), 4.75 (1H, s, H-OHb), 4.59 (1H, d, J = 5.2 Hz, H-OHc), 4.49 (1H, t, J 
= 6 Hz, H-OHf), 4.14 (2H, m, Hacetamido), 3.81 (1H, m, H-CHd), 3.68-3.63 (1H, m, H-CHf), 3.60-
3.50 (1H, m, H-CHc), 3.60-3.50 (2H, m, H-CH2(3-propanamide)), 3.55-3.36 (3H, m, H-CHf’,e,b), 2.63 
(2H, t, J = 6.8 Hz, H-CH2(2-Propanamido)).   
 
13C NMR (DMSO, 100 MHz): δ 169.8, 168.0, 167.0, 165.3, 142.2, 139.6, 138.8, 131.4, 131.0, 
129.1 (x2) 118.9 (x2), 115.5, 115.2, 114.4, 99.9, 74.5, 70.8, 69.8, 66.9, 65.3, 61.2, 36.3, 35.9.  
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HRMS Calcd for [M+H]+: 589.1889 Found 589.1890, Calcd for [M+Na]+: 611.1708 Found 
611.1708.   
 
3-((4-azidobenzamido)propanamido)-5-((1O-β-D-galactosyl)acetamido)benzoic 
acid(4): Compound  15 (668 mg, 0.85 mmol) was deprotected according to the general 
proceudre.  The crude product was triturated with water to yield 4 as a white amorphous solid 
(379 mg, 0.64 mmol, 76%).   
 
1H NMR (DMSO, 400 MHz): δ 12.94 (1H, s, H-CO2H), 10.19 (1H, s, H-NHamide), 9.97 (1H, s, 
H-NHamide), 8.62 (1H, t, J = 5.4 Hz, H-NHamide), 8.21 (1H, s, H-Ar), 7.98 (1H, s, H-Ar), 7.90 (1H, 
s, H-Ar), 7.89 (2H, d, J = 8.4 Hz, H-Ar), 7.19 (2H, d, J = 8.8 Hz, H-Ar), 4.82 (2H, d, J = 4.4 Hz, 
H-OHd), 4.75 (1H, s, H-Hα), 4.75 (1H, s, H-OHb), 4.59 (1H, d, J = 5.2 Hz, H-OHc), 4.49 (1H, t, J 
= 6 Hz, H-OHf), 4.14 (2H, m, Hacetamido), 3.81 (1H, m, H-CHd), 3.68-3.63 (1H, m, H-CHf), 3.60-
3.50 (1H, m, H-CHc), 3.60-3.50 (2H, m, H-CH2(3-propanamide)), 3.55-3.36 (3H, m, H-CHf’,e,b), 2.63 
(2H, t, J = 6.8 Hz, H-CH2(2-Propanamido)).   
 
13C NMR (DMSO, 400 MHz): δ 169.8, 168.0, 167.0, 165.3, 142.2, 139.6, 138.8, 131.4, 131.0, 
129.1 (x2) 118.9 (x2), 115.5, 115.2, 114.4, 99.9, 74.5, 70.8, 69.8, 66.9, 65.3, 61.2, 36.3, 35.9.   
 
HRMS Calcd for [M+H]+: 589.1816 Found: 589.1879. 
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3-((4-azido-2,3,5,6-tetrafluorobenzamido)propanamido)-5-(1-O-(α-D-
mannosyl)acetamido)benzoic acid(23):  Compound  21 (599 mg, 0.700 mmol) was deprotected 
according to the general procedure which gave 23 as a a light yellow amorphous solid (396 mg, 
599 µmol, 86%).  1H NMR (400 MHz, CD3OD) δ 8.22 (d, J = 20.2 Hz, 1H), 7.96 (dd, J = 44.2, 
18.4 Hz, 2H), 4.27 (dd, J = 33.3, 15.2 Hz, 2H), 4.03 (s, 1H), 3.86 (dd, J = 24.8, 13.5 Hz, 3H), 
3.65 (ddd, J = 65.7, 35.0, 26.2 Hz, 5H), 2.74 (t, J = 6.5 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 
170.89, 170.50, 169.96, 166.27, 138.69, 137.66, 132.05, 117.67, 114.92, 98.23, 69.83, 69.44, 
67.45, 65.98, 62.61, 61.71, 53.72, 37.05, 31.23, 30.01, 21.16, 21.02, 20.94, 14.55. 
 
3-((4-azido-2,3,5,6-tetrafluorobenzamido)propanamido)-5-(1-O-(β-D-
galactosyl)acetamido)benzoic acid(24):  Compound 22 (707 mg, 0.83 mmol ) was 
deprotected according to the general procedure to give 24 (399 mg, 0.60 mmol, 73%) as a pale 
yellow syrup that turned to a pale yellow foam on under vacuum.     
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Bead Preperation(6): To a suspension of Carboxy Polystyrene HL (100-200 mesh) 
1%Divinyl Benzene (250 mg) in dichloromethane (25 mL) was added Ethylene Diamine (25 mg, 
0.42 mmol), N,N-Dimethyl-4-Amino-Pyridine (15 mg, 0.12 mmol) and N,N’-
Diisopropylcarbodiimide (50.6 mg, 0.40 mmol).  The reaction was let stir over night.  The bead 
was filtered and washed with ethanol (3x100 mL).  The resin was immediately subjected to the 
same conditions for a second cycle.  The Kaiser test was positive for free amine on the surface of 
the bead. 
 
General conditions for functionalizing resin surface:  The resin was allowed to swell in 
DMF for 6 hours prior to starting the cycle.  To the resin (~10 mg, 1.00 mmol/g loading 
capactiy) in DMF (1 ml) was added 3, 4, 23, or 24 (5 mol equivalents), HATU (5 eq) and 
iPr2NEt (10 eq).  The resin was stirred for 24 h at rt.  The resin was filtered off and subjected to 
these conditions to ensure complete coupling.  The phenol sulfuric acid assay was used to 
measure the loading of the resins. 
 
Phenol sulfuric acid assay:  Calibration curves were prepared as described (Dubois 1956) 
for D-mannose and D-galactose.  For resin containing samples, the procedure was slightly 
modified.  A one mg/ml resin suspension was prepared by ultrasonicating 1 mg of resin with 1 
ml of DI water.  100 µl of this suspension was transferred to a clean test tube and diluted with 
300 µl of DI water.  100 µl of an 80% phenol (v/v) solution was added followed by slow addition 
of 1 ml conc. H2SO4.  The test tube was vortexed (being careful, this tube gets really hot!) and let 
cool back to rt over 20 minutes.  One ml of this solution was carefully syphoned off to prevent 
the udpate of flocculated resin, and it's absorbance measured at the reported wavelengths.    
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Cross Linking Experiments: Test tubes were charged with 3 ml of 1 mg/ml BSA solution 
and let incubate at 37 °C for one hour.  The solutions were poured out and 1 mg of resin was 
added to individual test tube, one TAPP per test tube.   To all test tubes was added 0.5 ml of 1 
ng/ml Concanavalin A.  The solutions were let incubate at 37 °C for 12 hours, in the dark, with 
gentle shaking.   The test tubes were transferred to the photoreactor, a rayonet RPR-100 from 
Southern New Englang Ultraviolet,  and irradiated with a 350 nm broadband light source for two 
hours.  The resins were filtered and collected into 1.5 ml microfuge tubes for rinsing. 
 
Rinsing Protocol: For all rinsing solutions:  1 ml of solution was added and the tubes were 
vortexed for 20 seconds.  The resulting suspension was centrifuged at 12,000 rpm for 10 
minutes.  The supernatant was carefully removed.  The rinsing solutions are 1 x DI water, 3 x 
10% aqueous DMSO, 3 x 25% aqueous DMSO, 3 x 75% aqueous DMSO, and 3 x DI water.  
The final rinsing solutions are to ensure a safe concentration of DMSO for the enzymatic 
liberation and cleavage of the bound proteins. 
 
Sample Preparation:  After cross-linking and rinsing, the resins were centrifuged at 12,000 
rpm for 10 minutes, and the supernatant was removed.  The resins were rinsed twice with 20 mM 
NH4HCO3, pH 7.4, buffer and resuspended by ultrasonication to give a final 1 mg/ml suspension 
in NH4HCO3.  Aliquots corresponding to 500 nm, 125 nm, 25 nm, and 12.5 nm of bound probe, 
were transferred to new microfuge tubes.  The tubes were centrifuged again and the supernatent 
removed in preparation for tryptic digest. 
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Trypsin Digestion:  To each sample was added 5 µl 20 mM NH4HCO3 and 5 µl 10x trypsin 
(0.1 mg/ml trypsin in 50 mM aqueous acetic acid).  The tubes were pulsed in a centrifuge to pull 
the contents to the tip of the microfuge tube and they were incubated for 2 hours at 37 °C with 
gentle shaking.  The tubes were centrifuged and the digest supernatant was removed to clean, 
labeled microfuge tubes.  To the tubes with the resins was added 20 µl 20 mM NH4HCO3 buffer 
and the tubes were vortexed for 20 seconds and centrifuged at 12,000 rpm for 1 minute.  The 
supernatant was combined with each samples respective digest solution.  This process was 
repeated one more time for microfuges tubes containing resin.  For each sample, both 2 hour 
digests and rinses were combined for 60 µl of peptide solution.  These solutions were allowed to 
incubate for 8 more hours at 37 °C before being subjected to mass spectrometric analysis. 
 
Mass spectrometry and analysis:  The peptide solution was analyzed by nano-LC-ESI Ion 
Trap with the intent of using Mascot (Perkins 1999) to search the NCBI database, limited to the 
peptide source organism, in the case of ConA, that is C. ensiformis (Jack Bean).  Analysis was 
performed by the Laboratory for Biological Mass Spectrometry, Department of Chemistry, 
Indiana University, Simon Hall 120B, 212 S. Hawthorne Drive, Bloomington, IN, 47405.   
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CHAPTER III 
INVESTIGATION OF SYNTHESIS AND AUTOMATED SYNTHESIS OF HIGHLY 
BRANCHED OLIGOSACCHARIDES 
 
 
Introduction 
 
 One major bottleneck to the study of carbohydrates, namely glycans, are the problematic 
routes to access homogenous samples for study.  There are three routes in which these 
biologically relevant compounds can be obtained.  Isolation from natural products is a widely 
shared endeavor of groups who are studying glycans (Yu 2012) and efforts have been made to 
simplify such tasks (Trader 2011).  Material throughput is a large limitation to this method due to 
the expensive and time consuming separations of complex mixtures.  Genetic engineering of 
metabolic pathways have been employed produce glycan substrates and intermediates (Mizanur 
2009).  This method also involves isolation from a heterogenic mixture, but in these cases, the 
target compounds have been amplified and obtaining homogeneous samples is possible.  The 
final route to accessing these compounds is through chemical synthetic methods. 
 Synthetic strategies are routinely carried out to produce biologically active glycan and 
glycoconjugates (Lakshminarayanan 2012, Boltje 2012).  Despite efforts, access to 
carbohydrates is still highly limited.  Many of these reasons can be attributed to one underlying 
feature of carbohydrates, their structural diversity (Chang 2011).  In brief, combining the number 
of regio- and stereoisomers for a particular pair of monosaccharides, with the number of possible 
monosaccharides, and with the number of linkages in oligosaccharides, the number of possible 
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compounds grows quickly, on the order of 103 for a trisaccharide library arbitrarily limited to 8 
monosaccharide building blocks just to give perspective. 
 Another challenge facing carbohydrate chemistry is the lack of understanding and 
predictability in the outcome of the glycosylation reaction.  There has been several efforts to 
probe these reactions (Crich 2004) but in spite of these efforts, no precise mechanism has been 
elucidated (Crich 2010).  Much effort can be invested in the preparation of a monosaccharide 
donor for glycosylation, and failure at this step is very costly.   
 The preparation of these monosaccharide donors has also not been trivialized.  Many 
donors can take six to seven synthetic steps to prepare, and in some cases upwards of 15 steps 
have been reported.  These steps involve differentiating the reactivity of hydroxyl groups in these 
polyols, which can lead to difficult to separate regioisomers and sensitive reactions.  
Development of synthetic routes to building blocks with similar protecting group features would 
allow for the use of general preparation techniques for donors as well as reproducible and 
predictable orthogonal deprotection of hydroxyl groups for chain elongation. 
 Automated chemical methods for carbohydrates would certainly benefit from having 
predictable deprotection conditions by allowing for the facile production of small arrays of 
glycans for study.  Routine scripts and standard reagent stocks could be used without concern for 
specific substrate.  This would be limited to cases where the glycosylation is easily controlled, 
such as in cases where the 2 position protecting group will anchimerically participate during 
glycosylation.    
 The nematode, Caenorhabditis elegans, has been shown to produce a series of 
oligosaccharides, 1-6 (Figure 3.1) (Guerardel 2001).  The structurally interesting feature of these 
saccharides is the heavily branched pattern on the galactose amine residue (4) as well as the 
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galactose residue (6).  The similarity in these structures would suggest the enzymes that are 
responsible for the production of these saccharides is most likey highly erroneous due the steric 
hindrance, and is likely the cause of the identification of such a structurally related set of 
oligosaccharides.  This highly branched pattern also poses a challenge to current synthetic 
methods and warrants investigation into the synthetic capabilities to produce such branched 
oligosaccharides.   
 
 
Figure 3.1  Structurally similar oligosaccharides isolated from the nematode C. elegans.  
 
 A specific C. elegans mutant, srf-3 (Cipollo 2004), was found to produce these 
carbohydrates in considerably reduced quantities.  This mutant variant of the nematode was also 
was found to display immunity to pathogen infection by Y. pestis, Y. pseudotuberculosis, and M. 
nematophilum.  It’s logical to implicate these saccharides as being key components in pathogen 
recognition of host cells.  One significant structural feature of this set of carbohydrates is the 
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core disaccharide unit Gal-β(1→3)-GalNAc.  This core saccharide is the well known TF antigen 
(Imamura 2005, Ju 2013)  and is a conserved feature of mucin type I proteins (Therkildsen 
1995).  Thus, it’s valid to assert a hypothesis that implicates the binding proteins that recognize 
these carbohydrates in C. elegans as well as recognize the TF antigen in mammals.   
 To probe the ability of creating a donor library for facile production of a series of 
oligosaccharides, concurrently investigating current glycosylation methods to achieve multiple, 
sterically hindered glycosyations, and providing synthetic access to an interestingly relevant set 
of oligosaccharides, pursuit of these targets seemed worthwhile.  Here in we report the synthesis 
of donors to investigate current methods to synthesize heavily branched and sterically hindered 
glycosylation reactions with standardized deprotection conditions and preliminary results of 
automation using fluorous tag assisted automated solution phase synthesis of heavily branched 
oligosaccharides. 
 
Results and Discussion 
 
   A protecting group strategy was devised keeping two ideas in mind, the first being 
minimal steps required for complete deprotection, and the second to be applicable to biological 
experimental platforms for studies that target the biological significance of such glycans.  
Protecting groups that are linked through an ester linkage were chosen to be the protecting 
groups for hydroxyl groups that are not incorporated into glycosidic bonds as  the hydrolysis of 
these functional groups occurring under quite mild alkaline conditions.  The envisioned protected 
carbohydrates (Figure 3.2) meeting those requirements exhibit acetyl, levulinoyl, and methyl 
esters as hydroxyl and carboxylate esters.  The reducing end of the sugar is modified with a 
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fluorous alkene, cis-3-(perfluorooctyl)propyloxy-2-butenol (Ftag), that serves as both a 
protecting group for the anomeric carbon at the reducing end as well as a handle for purification 
that is critical for automated synthetic methods.   This paritcular handle works in combination 
with fluorous silica gel and is known as fluorous solid phase extraction (FSPE). 
 
Figure 3.2 Protected saccharide targets from C. elegan.   
 
 The six target oligosaccharides, all containing the core disaccharide Gal(β1→3)GalNAc, 
can be prepared from four protected disaccharides, 13-16, (Figure 3.3) that each have a unique 
protecting group pattern to allow for orthoganol deprotection conditions to selectively free 
hydroxyls for glycosylation.  Disaccharide 13 would be an intermediate for target trisaccharide 1, 
disaccharide 14 would give rise to pentasaccharide 3, core 15 would be employed to access 
target pentasaccharide and hexasaccharide 5 and 6, and 16 would be used for the preparation of 
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tetrasaccharide and pentasaccharide 2 and 4.  Retrosynthetic analysis of the general disaccharides 
results in a need for four donor monosaccharides, two galactose amine monosaccharides for the 
reducing end carbohydrate, and two galactose monosaccharides for the nonreducing end of the 
disaccharide , 17-20.   
 
Figure 3.3  Retrosynthetic analysis of core disaccharide to access the six oligosaccharide 
targets.   
 
 The branching pattern of all C. elegans saccharides requires two orthogonal protecting 
groups, one to protect hydroxyls for glycosylation a glucose donor, P1 (17-20),  and one for 
glycosylation with a galactose or glucuronic acid donor, P2 (17-20).  The desired ester groups 
and the azide group in the protected products, 7-12, excludes protecting groups that require 
strongly basic or reductive conditions for liberation of the hydroxyl group.  The acidic 
glycosylation conditions exclude acid sensitive groups like methoxy benzyl ethers or 
trimethylsilyl ethers.  However, other silyl ethers are known to have longer half lives in acidic 
conditions and have many known cleavage conditions across a range of solution pH, allowing for 
mild, orthogonal deprotection of silyl ethers in presence of esters.  Specifically, tert-
butyldiphenylsilyl (TBDPS) ethers are well known and extensively used in oligosaccharide 
51 
 
 
synthesis.  One convenient feature of this protecting group is its selective protection for primary 
hydroxyls, making it ideal for use in building blocks 17 and 19.  Currently, there is no evidence 
of being able to protect four position hydroxyls of carbohydrates with the TBDPS ether, and 
many of the other silyl groups might be too labile under glycosylation conditions, another 
protecting group will need to be employed for donors, 18 and 20.  To avoid unnecessary 
deprotection steps, a strategy to deprotect both four and six positions of 18 and 20 would be 
ideal.  Benzylidene acetals have been shown to be stable to the acidic conditions of glycosylation 
and glycosidic bonds are not susceptible to solvolysis under these conditions.  Preferential acetal 
formation with 1,3 diols over 1,2 diols have been applied frequently to carbohydrates to protect 
the four and six hydroxyl groups and would be a suitable protecting group for both donors, 18 
and 20.  The final protecting group needed to protect the three position hydroxyl of the four 
donor compounds ought to cleave under relatively nuetral conditions to make it orthogonal to the 
basic cleavage conditions of ester groups and the acidic cleavage conditions of acetals.  One 
protecting group that can conform to these requirements is the levulinate protecting group.  This 
ester will selectively cleave under very mild acidic conditions in the presence of hydrazine.   
 With this strategy in mind, seven donor compounds, 21-28 (figure 3.4), were envisioned 
to be necessary for the preparation of all six targets (table 3.1).  Trichloroacetimidate (TCA) 
donors (shmidt 1980) were chosen for ease of preparation, robust reactivity, mild activation 
conditions, and solubility of byproducts.  TCA donors have been employed in numerous 
glycosylation reactions, in various solvents, under a wide range of temperatures, for a large 
variety of substrates .  Soluble byproducts are desired to make this synthetic route amenable to 
automated solution phase chemical synthesis of oligosaccharides .  One extra galactosamine 
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donor was prepared to simplify deprotection of the protected saccharide to obtain target 
saccharide 2.     
 
Figure 3.4  Glycosyl donors needed to synthesize all six oligosaccharide targets. 
Table 3.1  Donors required by target 
Target Donor 1 Donor 2 Donor 3 Donor 4 
1 23 28 27 - 
2 22 25 27 26 
3 23 25 27 26 
4 23 24 27 - 
5 21 23 27 - 
6 23 24 27 26 
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 Donors 26, 27, and 28 have been prepared previously (Wayne 2010).  Preparation of 
compound 21 (scheme 3.1) originated from the known 1,3,4,6-tetra-O-acetyl-2-deoxy-2-azido-
α/β-D-galactoside, 29 (Mukherjee 2008).  The glycosidation with p-methoxyphenol was 
achieved with catalytic triflic acid to produce acetal 30 in good yield.  Basic solvolysis of the 
three esters with sodium in methanol, subsequent protonation with DOWEX 50WX8 cation 
exchange resin, followed by selective acid catalyzed acetal formation with benzaldehyde dimthyl 
acetal to transform triester 30 to the 4,6-O-benzylidene acetal 31 in 84% yield over three steps.  
Acylation of the sole alcohol with levulinic acid was effected under standard carbodiimide 
coupling condition to provide 32 in excellent yield, 91%.  Oxidative cleavage of the p-
methoxyphenyl protecting group with ceric ammonium nitrate (CAN) gave poor yield, but 
enough material to carry onto TCA formation with catalytic DBU and CCl3CN, well known 
conditions, to obtain target donor 21, in 11% over 7 steps from known compound 29.   
 
Scheme 3.1   Synthetic route to donor 21. 
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 From compound 32 (scheme 3.2), hydrolysis of the benzylidene acetal was accomplished 
with aq. trifluoroacetic acid and the free hydroxyl groups were acylated with acetic anhydride to 
afford compound 33 in 68% yield over both steps.  Cleavage of the phenolic ether with CAN and 
then formation of TCA donor 22 with standard conditions provided in modest yield, 17% over 9 
steps from known compound 29.   
   
 
Scheme 3.2  Preparation of donor 22. 
  
 Access to donor 23 originated from compound 30 (scheme 3.3).  Basic hydrolysis of the 
esters, acidification, and regioselective silylation of the primary hydroxyl group furnished silyl 
ether 34 in 73% yield over all three steps.  Trimethyl orthoacetate and cat. tosylic acid was 
employed to form an orthoester with the cis diol of 34, which was regioselectively opened to the 
axial ester.  The final hydroxyl group was converted to the levulinate ester with levulinic acid 
and EDC to provide compound 35 in 85% yield over all three steps.  Cleavage of the p-
methoxyphenyl ether was achieved with CAN and the hemiacetal was transformed to TCA 
donor, 23 in total of 29% over 9 steps from 29. 
With all necessary galactosamine donors prepared, attention was turned to the two necessary 
galactose donors, 24 and 25.  The route to 24 initially started from known p-methoxyphenyl 4,6-
O-benzylidene-β-D-galactopyrannoside, 36 (scheme 3.4).  Regioselective protection of the three 
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position hydroxyl with tert-butylchlorodimethylsilyane was achieved after 24 hours in DMF to 
give isomer 37 in 66% yield, which was easily separated from the 2-TBS regioisomer on silica 
gel.  The acylation of alcohol 37 initially proved unreactive towards standard conditions until 
catalytic DMAP was added.  The reaction then proceeded, slowly, over 
 Scheme 3.3  Synthetic scheme for donor 23. 
 
8 hours, which was then directly subjected to desilylation conditions.  Standard conditions which 
employ TBAF as the fluoride donor was presumed to be provoking migration of the two position 
acetate to the three position acetate.  Buffered conditions with acetic acid didn’t prevent 
migration completely, but switching fluoride source to thriethylamine trihydrogen fluoride 
complex, buffered with Et3N, provided compound 38 in 68% yield over both steps.  Alcohol 38 
was converted to levulinate ester 39 with standard carbodiimide coupling in great yield.  
Oxidative cleavage of the p-methoxyphenyl ether was completed with CAN and followed by 
TCA formation at the hemiacetal to furnish donor 24 in 29% yield over 6 steps.   
 The final galactose building block needed for the preparation of the oligosaccharide 
series began with known p-methoxyphenyl 6-O-tert-butyldiphenylsilyl-β-D-galactopyrannoside, 
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40 (scheme 3.5).  The cis diol was first converted to an orthoester using trimethyl orthoacetate, 
the remaining hydroxyl was acylated with acetic anhydride under basic conditions,  and then the 
orthoester was regioselectively opened to the axial ester to give alochol 41 in 65% yield over all 
three steps.  The remaining three position hydroxyl group was converted to the levulinate ester 
under standard coupling conditions to access compound 42 in high yield.  The anomeric ether 
was oxidatively cleaved with aqueous CAN and converted to TCA donor 25, in 47% yield over 6 
steps. 
 
Scheme 3.4  Preparation of donor 24.
 
Scheme 3.5  Synthesis of donor 25. 
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 With all the necessary intermediate donor targets prepared, efforts were directed towards 
the glycosylation and deprotection conditions to finish preparing the six target oligosaccharides.  
The main question in this study is if it is possible to prepare the highly branched oligosaccharide 
structures that feature the 3,4, and 6 glycosylation pattern (4 and 6) with current chemical 
methods.  Thus, target 4 was chosen for preliminary experiments.  The first glycosidation 
reaction will install the fluorous tag compound at the reducing end of target 4 prior to saccharide 
extension glycosylations.  The initial glycosidation reaction, (Table 3.2, entry 1) was surprisingly 
selective for formation of the β anomer.    Literature precedent had given the hypothesis that this 
building block would give good selectivity for the α anomer (Zhitao Li, Seeberger).  Further 
discussion with Zhitao Li indicated that he only observed his reported selectivity with 
deactivated acceptors and the selectivities were substrate (acceptor) controlled.  Work published 
later (Zhitao Li) indicated that with simple nucleophiles give excellent β selectivities with 2-
deoxy-2-azido TCA donors.  The strereochemistry of the linkage of these carbohydrates in vivo 
is unknown but are presumed to be α due to core structural similarities of these carbohydrates 
and the mucin glycans, which are found as α O-linked glycosides.   
 There is evidence in literature (Park 2007) that suggests using additives during 
glycosylation can influence stereoselectivity of the resulting glycosidic bond.  Specifically, the 
addition of 10 equivalents of thiophene could lead to the formation of α glucosides presumably 
through coordination of the sulfur atom of thiophene to the oxocarbenium intermediate (Scheme 
3.6) in the β conformation, which is assumed to be due to steric effects based on computational 
studies.  Investigation of this additive did have a large effect on the reaction outcome, shifting 
the results to about a 1:1 ratio of α to β.  After thiophene was shown to be only mildly able to 
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controlling the selectivity of the glycosidation completely, it was hypothesized that a 
participating solvent might have a more drastic effect in the outcome of the reaction. 
 
Table 3.2  Glysoylation of donor 21 with acceptor Ftag.  Selectivities were determined on by 
isolated mass.  All glycosylations were carried out using 3 eq. of 21, 0.3 eq. TMSOTf, 1 eq. Ftag 
alcohol, and 10 eq. thiophene when used.  The reaction was run at a concentration of 0.4M with 
respect to donor 21.  aConcentration of donor 21 was 0.01M with all other equivalents held 
constant. 
 
Entry Solvent Thiophene Temperature Yield Selectivity 
1 CH2Cl2 N/A 25 °C 80 All β 
2 CH2Cl2 10 eq. 0 °C 70 1.2:1 α/β 
3 CH2Cl2 10 eq. 25 °C 73 1.1:1 α/β 
4 Et2O N/A 0 °C 30 2.5:1 α/β 
a5 Et2O N/A 0 °C 82 3.5:1 α/β 
 
 The reaction with thiophene suggested that cooridanation of the intermediate can be a 
solution to the stereochemical outcome of the glycosidation and thus, solvents effects were 
explored.  Participating solvents are well known in organic synthesis, but solvents of particular 
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Scheme 3.6  Hypothesized role of thiophene in generation of α glycosides. 
    
 interest in glycosylations are ether, acetonitrile, and toluene.  All three of these solvents posses 
either lone pairs or enough electron density to donate to the oxocarbenium cation intermediate 
during glycosyalation.  Acetonirtrile has been shown to primarly prefer to coordinate to donors 
from the α face of the cation, giving rise to β anomer products while conversely to that, ethers, 
notable diethyl ether and dioxane, have been used due to their preferential coordination to the 
carbocation via the β face, giving rise to favored α glycosides.  Diethyl ether was then 
investigated as the solvent during glycosylations with the fluorous tag acceptor.  In diethyl ether, 
the reaction provided a 5:2 mixture in favor of the α anomer but the yield of the reaction fell to 
only 30%.  While the selectivity for the α anomer did improve, the magnitude was not adequate 
when considering the cost of all the subsequent donors and poor yield, other solutions were 
investigated.  
 Di-tert-butylsilylene protected carbohydrates have started appearing frequently in 
oligosaccharide synthesis in recent literature.  Similar to many reactions involving 
carbohydrates, the effect of these groups is heavily dependent on the carbohydrate.  These groups 
have been shown to invoke a ring flip of the carbohydrate during glycosylations in some cases, 
or just prevent the formation of one anomer through steric blockage of a particular face of the 
carbohydrate.  The use of these with 2-deoxy-2-galactose derivatives have now appeared, studies 
into their mechanistic effects have not yet been pursued to my knowledge.  However, in one 
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case, it was shown that such a silylene based 2-deoxy-2-azido galactose based derivative gave 
excellent α selectivity.  Thus donor 45 was envisioned to provide good α selectivities while still 
allowing for a simultaneous deprotection of both the four and six position hydroxyls (Scheme 
3.7).   
 
Scheme 3.7  Preparation of donor 45. 
 
 Synthesis of donor 45 started from previously prepared 30 (Scheme 3.7).  The acetate 
protecting groups were removed by basic solvolysis with sodium in methanol, which was 
acidified with DOWEX acidic resin, and the resulting triol was converted to the 4,6 silylene 46 
in modest yield.  Alcohol 46 was transformed to levulinate ester 47 with standard carbodiimide 
coupling conditions in good yield.  The p-methoxyphenyl ether of 47 was oxidatively cleaved 
with CAN, and the resulting hemiacetal was transformed to the TCA donor, 45, with base and 
CCl3CN in 27% yield over 8 steps from 29. 
 Donor 45 was explored as a glycosyl donor with the fluorous tag alcohol acceptor (Table 
3.3).  The reaction in methylene chloride at room temperature afforded only α anomer in 
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Scheme 3.8  Proposed silyl group influence with stereoselectivity.  
 
good yields.  The selectivity for formation of the α anomer is thought to arise out of steric 
hinderance of the α face (scheme 3.8).  Persumable, after formation of the carbocation, the 
oxygen will donate its electrons into the vacant carbocation orbital, and the resulting 
planarization puts structural strain on the 4,6 fused ring system.  In turn, this causes the 
secondary ring structure to pucker.  It’s hypothesized (Imamura 2005) that the loan pair on the 
oxygens in the silylene donating towards the carbocation will influence the tilt of the tert-butyl 
groups to be over the carbocation, successfully hindering the β face of donor 45. 
 With glycosylation conditions suitable for automation elucidated, the fluorous tag 
assisted solution phase automated synthesis and investigation of these glycosylations 
commenced.  Automation was performed on a Chemspeed Automation Synthesis Workstation 
1000 robotics platform (ASW).   A series of macrotasks were designed (Table 3.3) that would be 
amenable to any of the protected targets (7-12).    The macro tasks were created such that when 
setting up new programs for a particular target, minimal changes would be necessary.  The only 
changes would be adjusting zones (specific vial locations), times and volumes.    
 Once the variable macro tasks were established, a program was designed to prepare 10 
and investigate current chemical methods' to achieve a heavily branched 3,4 and 6 position 
glycosylations (figure 3.5).  The envisioned route started with TMSOTf catalyzed glycosidation 
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Table 3.3  Program flow for ASW protocol for 10. aOnly if task includes intentional waits or 
time consuming tasks.  Where A, D, RV, RT, TLC, FSPE, WASTE, COLLECT, DIRECT, 
MeOH, 80MeOH, DS are variables that are set for each macro task prior to running.    
Macro Task Step Sub Tasks Operational  
Timea 
Evaporation 1 
2 
3 
Heat/Cool 
Apply vacuum 
Heat/Cool 
45 minutes 
Glycosylation 1 
2 
3 
4 
5 
6 
7 
8 
Transfer A to RV 
Transfer D to RV 
Heat/Cool 
Transfer TMSOTf to RV 
Wait for RT 
Transfer TLC aliquot 
Transfer Et3N 
Evaporation 
Variable 
Drying Cycle 1 
2 
 
Transfer toluene to RV 
Evaporation 
Repeat from 1 twice 
2 hours 
FSPE 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Set FPSE to WASTE 
Transfer RV to FSPE 
Transfer MeOH to RV 
Transfer H2O to RV 
Transfer RV to FSPE 
Transfer 80MeOH to FSPE 
Set FSPE to COLLECT 
Transfer MeOH to FSPE 
Set FSPE to DIRECT 
Transfer FSPE to next RV 
Evaporate 
Repeat from step 8 
About 2 hours 
Deprotection 1 
2 
3 
4 
Transfer DS to RV 
Heat/Cool 
Wait for RT 
Transfer TLC aliquot 
Variable 
 
 of 45 with Ftag followed by cleavage of the levulinic ester with hydrazine hydrate.  The 
reaction was quenched with water and  loaded directly on to FSPE for purification from the 
reaction mixture.  The resulting acceptor was then subjected to glycosylation with donor 25.  
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Directly after the reaction, desilylation was performed with TBAF and HOAc in DMF.  The 
reaction was again loaded directly onto FSPE for purification of the fluorous containing material.  
The glycosylation of the presumed triol intermediate was attempted using six equivalents of 
donor 27.   The program (Table 3.4) made use of the previously described macro tasks and 
included the removal of aliquots for TLC. 
  
 
Figure 3.5  Visual diagram for automated synthetic protocol. 
 After the program was run, the obtained fluorous compounds were analyzed and program 
and reaction conditions produced a highly impure sample.  No product was readably discernible 
from the mixture, but one convenient aspect of solution phase automation synthesis is the ability 
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Table 3.4  Program for ASW to obtain target 10.  Macro tasks and simple tasks included. 
Step Macro Task Variables 
1 Drying Cycle All Reactor Vials 
2 Glycosylation Reactor Vial 1 
0.45 ml Ftag 
0.45 ml 45 
25 °C 
0.1 ml TMSOTf 
45 minutes 
3 Deprotection 0.4 ml Hydrazine Solution in DMF 
25 °C 
180 minutes 
4 Liquid Transfer 0.1 ml H2O to Reactor Vial 1 
5 FSPE Source: Reactor Vial 1 
0.7 ml Crude Volume 
FSPE station 1 
Destination: Reactor Vial 2 
6 Drying Cycle  
7 Glyosylation Reactor Vial 2 
No Acceptor Transfer 
0.9 ml 25 
0 °C 
0.1 ml TMSOTf 
45 minutes 
8 Deprotection 0.5 ml TBAF/HOAc in DMF 
25 °C 
60 minutes 
9 FSPE Source: Reactor Vial 2 
0.7 ml Crude Volume 
FSPE station 2 
Destination: Reactor Vial 3 
10 Drying Cycle  
11 Glycosylation Reactor Vial 3 
No Acceptor Transfer 
1.8 ml 27 
0 °C 
0.1 ml TMSOTf 
45 minutes 
13 Liquid Transfer 0.5 ml DMF to Reactor Vial 3 
14 FSPE Source: Reactor Vial 3 
0.7 ml Crude Volume 
FSPE station 3 
Destination: Reactor Vial 4 
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to take TLC aliquots.  TLC analysis of the aliquots quickly identified the problem step as being 
related to the desilylation conditions.  To verify that this was indeed the problem step, bench top 
methods were employed.  This can be done without needing to worry about later optimization on 
the platform as optimization on the bench top translates directly to solution phase automated 
synthesis.   
 
Scheme 3.9 
 
 Starting with donor 45, glycosidation with the fluorous tag was performed in methylene 
chloride at room temperature (Scheme 3.9).  The crude was directly subjected to hydrazine under 
mild acidic conditions to cleave the levulinate ester to provide acceptor 48 in 53% yield over 
both steps.  Donor 25 was subjected to glycosylations conditions with acceptor 49 to produce 
disaccharide 50 in excellent yield, 96%.  Desilylation with TBAF and acetic acid conditions (as 
used on the ASW platform) and TBAF resulted in several decomposed products as indicated by 
TLC analysis of the reaction mixture (Scheme 3.10).  Triethylamine trihydrogen fluoride 
complex was one condition that seemed to provide only one product as seen by TLC.  This 
condition was persued and 49 was subjected to triehtlymine trihydrogen fluoride buffered with 
triethylamine, which was completely consumed after 3 days.  The reaction produced what is 
presumed to be an inseparable mixture of 50 and 51 based on 1H NMR and 13C NMR, in good 
yield.  The mixture was subjected to glycosylations conditions (Scheme 3.11) with donor 27 to  
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Scheme 3.10  Desilylation conditions investigated for 49.   
 
investigate the possibility of forming multiple glycosidic bonds in one pot of a 4,6 diol after the 
three position has already been incorporated into a glycosidic bond.  Six equivalents of donor 27 
were initially used but after all the donor had decomposed, several compounds were present by 
TLC analysis.  Another six equivalents of 27 were added which resulted in several spots on TLC 
to vanish.  Separation of the material is possible, but currently, only HRMS has been successful 
in characterizing the compound.   The hypothesized products are compounds 10 and 52, which 
were obtained in 44% yield, both of which feature the 3,4,6 branching pattern.    
 
 
Scheme 3.11  Triple glycosylation on 6' and 4,6 diols of mixture of 51 and 52. 
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Conclusion 
 Many methods are available for obtaining glycans but chemical synythetic methods are 
highly attractive for obtaining chemically well defined structures.  The attactiveness will further 
grow as combinatorial chemical methods continue to improve.   Reported here in this project is 
the rational design of monosaccharide building blocks that could be employed for the rapid 
production of an array of related oligosaccharides.  One interesting challenge of this 
carbohydrates investigated was the possibility to perform multiple glycoslyations in one step as 
well as investigate the capabilities of current methods to affect a 3,4, and 6 glycosylation pattern 
on a singular monosaccharide unit.  Despite poor desilylating conditions, it has been shown here 
that such reactions are possible with current methods. 
 To expand on this, it has been shown here how solution phase automated methods can be 
used to probe glycosylation and deprotection conditions by allowing for stepwise monitoring of 
the performed reactions.  This is unique only to solution phase automated methods, other 
methods such as those making use of solid supports do not have this utility.  Another issue with 
solid supports is the optimization conditions necessary for each step do not simply translate due 
the solid support.  One major concern is that concentration is hard to control in biphasic reactions  
which can have huge impacts on glycosylation outcomes.  Deprotection reagents and solvents 
can be adsorbed onto the resin which can have detrimental effects on subsequent reactions.  One  
other large concern I would have is that solid phase typically calls for 10 equivalents of donor for 
each glycosylation.  If trying to do such a glycosylation as shown here, the number of 
equivalents needed could be in incredibly wasteful excess, even if possible.  Solution phase 
methods combined with a good rational design of building blocks allows for minimal reaction 
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optimization and programming in attempts to construct arrays of oligosaccharides that would be 
useful in biological studies. 
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Experimental Section 
General: All commercially available compounds were purchased from TCI, Sigma Aldrich, or 
Fisher Scientific; they were reagent grade and used without further purification.  For sensitive 
reactions, solvents were dried prior to use by distillation from a suitable drying agent.  Column 
chromatography was performed with ZEOprep ECO silica gel 60 with 40-63 µm particle size 
(American International Chemical).  Reactions were monitored using thin layer chromatography 
coated with a 0.25 mm layer of silica gel 60 F254 (Sorbent Technologies).  Compounds were 
visualized with UV light and/or 5% v:v sulfuric acid in ethanol.  1H NMR and 13C NMR were 
performed with either a Varian i400 MHz or Varian i500 spectrometer, or otherwise noted.  All 
1H NMR peak assignments were made using solvent residual peaks as an internal standard 
(DMSO δ 2.50 ppm, CDCl3 δ 7.26 ppm, and CD3OD δ 3.31) as were 13C NMR peak assignments 
(DMSO δ 39.51 ppm, CDCl3 δ 77.31 ppm, and CD3OD δ 49.00) and supported using 1H-1H 
COSY experiments as needed.   High resolution mass spectra were obtained with a Thermo 
Electron Corporation MAT 95XP-Trap for compound characterization.  Automation was 
performed on a modified Chemspeed ASW-1000 robotics platform. 
 
 
Synthesis of p-methoxyphenyl 3,4,6-tri-O-acetyl-2-deoxy-2-azido-α/β-D-
galactoside (30).  A solution of 1,3,4,6-tetra-O-acetyl-2-deoxy-2-azido-α/β-D-galactoside 
(7.26 g, 19.4 mmol) and 4-methoxyphenol (2.9 g, 23 mmol) in methylene chloride (50 ml)  under 
argon was cooled to 0 °C in an ice bath while stirring.  Trifluoromethanesulfonic acid (0.52 ml, 
5.8 mmol)   was added dropwise (0.52 ml in 5 minutes).  The reaction was removed from the ice 
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bath and let stir for 16 hours at room temperature.  The  reaction was diluted with methylene 
chloride (300 ml) and the organic layer was washed with DI water (3x250 ml), sat. sodium 
bicarbonate (3x250 ml) and dried over Na2SO4.  The solvent was removed in vacuo and the 
crude oil was purified by column chromatography on silica gel (30% EtOAc in Hexanes) to 
afford 30 (6.49 g, 14.83 mmol, 76%) as a light yellow oil which turned to a white foam under 
high vac.  
 
1H NMR (CDCl3, 400 MHz) δ 7.03 (d, J = 9.1 Hz, 2H), 6.83 (d, J = 9.1 Hz, 2H), 5.56 (dd, J = 
11.1, 3.2 Hz, 0.75H), 5.51 (d, J = 3.2 Hz, 1.5H), 5.37 (d, J = 2.8 Hz, 0.25H), 4.84 (dd, J = 10.9, 
3.3 Hz, 0.25H), 4.79 (d, J = 8.0 Hz, 0.25H), 4.39 (t, J = 6.6 Hz, 0.75H), 4.21 (dd, J = 11.3, 6.9 
Hz, 0.25H), 4.17 – 4.05 (m, 2H), 3.99 – 3.90 (m, 0.5H), 3.82 – 3.72 (m, 3.75H), 2.16 (d, J = 5.0 
Hz, 3H), 2.11 – 1.95 (m, 6H);  
 
13C NMR (CDCl3, 100 MHz) δ 170.54, 170.25, 170.06, 170.01, 156.18, 155.90, 151.05, 150.47, 
118.98, 118.49, 114.95, 114.86, 102.16, 98.21, 71.20, 68.41, 67.76, 67.65, 66.47, 61.78, 61.54, 
60.91, 57.63, 55.90, 20.92, 20.86.; 
 
HRMS Calcd for [M+Na]+: 460.1332  Found: 460.1333. 
 
Synthesis of p-methoxyphenyl 2-deoxy-2-azido-4,6-O-benzylidene-α/β-D-
galactoside (31): To a solution of compound 30 (1.07g, 2.45 mmol) in methanol (5 ml) was 
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added solid sodium (0.056 g, 2.45 mmol).  The reaction was let stir for 1 hour at room 
temperature.  The base was neutralized with DOWEX 50WX8 (H+) cation exchange resin.  The 
resin was filtered and rinsed with methanol.  The methanol was removed in vacuo and trace 
methanol or water was removed by co-evaporation with toluene (3 x 5 ml).  The crude product 
was used directly in the next step.  A flask containing the crude product was flushed with argon, 
cat. p-toluenesulfonic acid monohydrate (0.045 g, 0.25 mmol) was added and the flask equipped 
with a stir bar.  To the solids was added acetonitrile (5 ml), followed by benzaldehyde dimethyl 
acetal (0.55 ml, 3.67 mmol) while stirring.  The reaction was let stir for 8 hours at room 
temperature.  The reaction was quenched with triethylamine (0.1 ml, 1.3 mmol) and the solvent 
was removed in vacuo.  The crude was purified by flash column chromatography on silica silica 
gel (20% to 30% EtOAc gradient in hexanes) to afford 31 (0.82 g, 2.05 mmol, 84%) as a pale 
yellow oil that turned into a white foam under high vac.   
 
1H NMR (CDCl3, 400 MHz) δ 7.51 (dd, J = 6.6, 3.2 Hz, 2H), 7.46 – 7.32 (m, 3H), 7.07 (dd, J = 
12.0, 5.2 Hz, 2H), 6.92 – 6.78 (m, 2H), 5.67 – 5.51 (m, 1.75H), 4.74 (d, J = 8.1 Hz, 0.25H), 4.44 
– 4.31 (m, 1.75H), 4.26 (dd, J = 12.7, 1.3 Hz, 0.75H), 4.17 (d, J = 3.3 Hz, 0.25H), 4.09 – 4.00 
(m, 1H), 3.87 (s, 1H), 3.77 (s, 3H), 3.69 (dd, J = 10.4, 3.3 Hz, 0.75H), 3.65 – 3.55 (m, 0.25H), 
3.49 (s, 0.25H), 2.72 (dd, J = 32.3, 10.0 Hz, 1H). 
 
13C NMR (CDCl3, 100 MHz) δ 155.9, 155.5, 151.3, 150.7, 137.4, 129.6, 128.5, 128.5, 126.6, 
126.4, 119.1, 117.8, 115.0, 114.8, 102.0, 101.7, 101.5, 98.4, 75.6, 74.6, 71.6, 69.4, 69.2, 67.6, 
66.9, 64.0, 63.6, 60.7, 55.9, 55.9;  
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HRMS Calcd for [M+Na]+: 422.1328 Found: 422.1341. 
 
 
Synthesis of p-methoxyphenyl 2-deoxy-2-azido-4,6-O-benzylidene-3-O-Levulinoyl-
α/β-D-galactoside (32):  To a solution of compound 31 (0.68 g, 1.71 mmol), EDC (0.49 g, 
2.56 mmol), and DMAP (21 mg, 0.17 mmol) in methylene chloride (20 ml) was added levulinic 
acid (0.26 ml, 2.56 mmol) and triethylamine (0.36 ml, 2.56 mmol) while stirring.  The reaction 
was let stir for 8 hours at room temperature.  The reaction was diluted with methylene chloride 
(100 ml), the organic layer was washed with 5% CuSO4(aq) (2 x 150 ml), DI water ( 2 x 150 ml), 
sat. sodium bicarbonate (3 x 150 ml) and dried over Na2SO4.  The solvent was removed in vacuo 
and the crude oil was purified by column chromatography on silica gel (20% to 40% EtOAc in 
hexanes) to afford compound 32 (0.77 g, 1.54 mmol, 90%) as a pale yellow oil that turned to a 
white foam under high vac.   
 
1H NMR (CDCl3, 400 MHz) δ 7.61 – 7.47 (m, 2H), 7.38 (dd, J = 4.7, 2.4 Hz, 3H), 7.13 – 7.02 
(m, 2H), 6.91 – 6.78 (m, 2H), 5.65 (d, J = 3.3 Hz, 0.75H), 5.61 – 5.52 (m, 1.75H), 4.87 – 4.77 
(m, 0.5H), 4.51 (d, J = 3.0 Hz, 0.75H), 4.39 – 4.20 (m, 1.25H), 4.15 (dd, J = 10.8, 8.1 Hz, 
0.25H), 4.05 (dd, J = 11.1, 3.3 Hz, 1.75H), 3.90 (s, 0.75H), 3.77 (s, 3H), 3.57 (d, J = 23.8 Hz, 
0.25H), 2.88 – 2.61 (m, 4H), 2.12 (d, J = 7.3 Hz, 3H);  
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13C NMR (CDCl3, 100 MHz) δ 206.33, 172.42, 172.31, 156.01, 155.57, 151.22, 150.62, 137.71, 
129.35, 128.46, 126.60, 126.40, 119.33, 117.74, 114.99, 114.79, 102.19, 101.23, 100.99, 98.16, 
73.60, 72.74, 72.27, 69.60, 69.30, 69.11, 66.70, 63.44, 60.35, 57.40, 55.92, 55.88, 38.15, 29.94, 
28.43, 28.36. 
 
HRMS Calcd for [M+Na]+: 520.1696 Found: 520.1679. 
 
 
 
Synthesis of 2-deoxy-2-azido-4,6-O-benzylidene-3-O-Levulinoyl-α/β-D-
galactopyranose trichloroacetimidate (21):  To a solution of compound 32 (149 mg, 299 
µmol) in a mixture of acetonitrile and water (1 ml, 4:1 acetonitrile/water) stirring at 0 °C in an 
ice bath was added solid ceric ammonium nitrate (492 mg, 897 µmol).  The reaction was 
removed from the ice bath and let warm to room temperature.  The reaction was let stir for 10 
minutes at room temperature.  The reaction was diluted with DI water (5 ml) and extracted with 
methylene chloride (3  x  15 ml).  The organic fractions were pooled and washed with DI water 
(3 x 50 ml), sat. sodium bicarbonate (3 x 50 ml), and dried over Na2SO4.  The solvent was 
removed in vacuo and the crude oil was filtered over a plug of silica gel (20% to 50% EtOAc in 
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hexanes) to afford the impure hemiacetal as an orange oil.  The compound was pure enough to be 
used directly in the next step.  To the crude in methylene chloride (1 ml) was added 
trichloroacetonitrile (0.36 ml, 2.99 mmol) and DBU (3 µl, 15 mmol).  The reaction was let stir 
for 1 hour at room temperature.  The solvent was removed in vacuo and purified by flash column 
chromatography on silica gel (30% EtOAc and 1% triethylamine in hexanes) to afford compound 
21 (30.3 mg, 57 µmol, 19%) as a pale yellow oil which turned to a white foam under high vac.   
 
1H NMR (500 MHz, CDCl3) δ 8.76 (s, 1H), 7.52 (dd, J = 7.5, 1.9 Hz, 2H), 7.46 – 7.31 (m, 3H), 
5.56 (s, 1H), 5.37 (dd, J = 11.0, 3.3 Hz, 1H), 4.55 (d, J = 3.0 Hz, 1H), 4.30 (dt, J = 10.9, 2.4 Hz, 
2H), 4.05 (dd, J = 12.8, 1.5 Hz, 1H), 3.97 (s, 1H), 2.85 – 2.60 (m, 4H), 2.12 (s, 3H).   
 
13C NMR (125 MHz, CDCl3) δ 206.45, 172.39, 163.88, 160.93, 137.60, 129.50, 128.54, 126.48, 
101.11, 95.66, 92.11, 91.12, 73.14, 70.19, 69.04, 65.13, 57.19, 38.11, 29.99, 28.40.   
 
HRMS Calcd for [M+Na]+: 557.0374 Found: 557.0385. 
 
 
Synthesis of p-methoxyphenyl 4,6-O-diacetyl-2-deoxy-2-azido-3-O-Levulinoyl-α/β-
D-galactopyranoside (33):  To a solution of compound 32 (0.58 g, 1.17 mmol) in methylene 
chloride (5 ml) was added aqueous trifluoroacetic acid (50% v/v, 10 ml).  The reaction was 
vigorously swirled at room temperature for 5-10 minutes until the starting material was 
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completely consumed by TLC.  The layers were separated and the water layer extracted twice 
with methylene chloride (2 x 20 ml).  The combined organic layer was washed with water (3 x 
50 ml), sat. sodium bicarbonate (3 x 50 ml), and dried over Na2SO4.  The organic solvent was 
removed in vacuo to afford a yellow oil and trace water was removed by coevaporation with 
toluene (3 x 5 ml).  To a solution of the crude product in methylene chloride (5 ml) was added 
triethylamine (0.98 ml, 7.01 mmol) and acetic anhydride (0.45 ml, 4.68 mmol).  The reaction 
was let stir for 8 hours at room temperature.  The reaction was diluted with methylene chloride 
(50 ml), washed with water (3 x 50 ml), washed with sat. sodium bicarbonate (3 x 50 ml), and 
dried over Na2SO4.  The organic layer was removed in vacuo and the crude  syrup was purified 
by flash column chromatography to afford 33 as a yellow syrup (0.39 g, 391 µmol, 68%).  
 
 1H NMR (CDCl3, 400 MHz) δ 7.04 (d, J = 9.1 Hz, 2H), 6.83 (d, J = 9.1 Hz, 2H), 5.63 – 5.47 (m, 
2.25H), 5.38 (dd, J = 9.9, 2.7 Hz, 0.25H), 4.87 – 4.76 (m, 0.5H), 4.39 (t, J = 6.5 Hz, 0.75H), 4.21 
(dd, J = 11.2, 7.0 Hz, 0.25H), 4.12 – 4.03 (m, 1.5H), 3.99 – 3.89 (m, 0.5H), 3.77 (d, J = 2.5 Hz, 
3.75H), 2.92 – 2.43 (m, 4.25H), 2.25 – 2.06 (m, 6H), 2.06 – 1.94 (m, 3H);  
 
13C NMR (CDCl3, 100 MHz) δ 206.27, 172.06, 170.58, 170.30, 155.93, 150.52, 119.02, 118.51, 
114.97, 114.89, 102.17, 98.28, 71.53, 71.24, 68.74, 67.74, 67.69, 66.44, 61.85, 60.98, 57.71, 
55.94, 38.09, 30.03, 28.08, 20.92, 20.90;  
 
HRMS Calcd for [M+Na]+: 516.1594  Found [M+Na]+: 516.1597, [2M+Na]+: 1009.3298. 
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Synthesis of 4,6-O-diacetyl-2-deoxy-2-azido-3-O-Levulinoyl-α/β-D-
galactopyranose trichloroacetimidate (22):  To a solution of compound 33 (371 mg, 752 
µmol) in a mixture of acetonitrile and water (2.2 ml, 4:1 acetonitrile/water) stirring at 0 °C in an 
ice bath was added solid ceric ammonium nitrate (1.24 g, 2.26 mmol).  The reaction was 
removed from the ice bath and stir for 10 minutes.    The reaction was diluted with DI water (10 
ml) and extracted with methylene chloride (3 x 35 ml).  The organic fractions were pooled and 
washed with sat. sodium bicarbonate (3 x 100 ml), Brine (3 x 100 ml), and dried over Na2SO4.  
The solvent was removed in vacuo and the crude oil was filtered over a plug of silica gel (20% to 
50% EtOAc in hexanes) to afford a crude orange oil.  The compound was pure enough to be used 
in the next step.  To a solution of the crude product in methylene chloride (2.2 ml) was added 
trichloroacetonitrile (0.75 ml,7.52 mmol) and DBU (11 µl, 80 µmol).  The reaction was let stir 
for 1 hour at room temperature.  The solvent was removed in vacuo and purified by flash column 
chromatography on silica gel (30% EtOAc and 1% triethylamine in hexanes) to afford compound 
22 (0.17 g, .32 mmol, 42%) as a colorless oil.  
 
1H NMR (500 MHz, CDCl3) δ 8.79 (s, 1H), 6.47 (d, J = 3.5 Hz, 1H), 5.67 (d, J = 8.5 Hz, 1H), 
5.49 (d, J = 2.2 Hz, 1H), 5.40 – 5.27 (m, 1H), 4.89 (dd, J = 10.8, 3.4 Hz, 1H), 4.37 (t, J = 6.4 Hz, 
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1H), 4.17 – 3.98 (m, 3H), 3.92 (dd, J = 10.7, 8.5 Hz, 1H), 2.86 – 2.41 (m, 4H), 2.21 – 1.90 (m, 
9H);  
 
 13C NMR (125 MHz, CDCl3) δ 206.50, 172.12, 172.05, 170.75, 170.72, 170.53, 170.42, 163.96, 
161.13, 161.03, 97.08, 94.94, 91.04, 90.69, 72.09, 71.93, 69.58, 69.39, 67.33, 66.46, 61.70, 
61.29, 60.89, 57.52, 38.18, 38.14, 30.18, 28.19, 28.13, 21.08, 21.05.  
 
HRMS Calcd for [M+Na]+: 553.0272 Found: 553.0251.  
 
 
 
Synthesis of p-methoxyphenyl 2-deoxy-2-azido-6-O-t-butyldiphenylsilyl-α/β-D-
galactoside (34): To a solution of compound 30 (2.29 g, 5.24 mmol) in methanol (15 ml) was 
added solid sodium (121 mg, 5.24 mmol).  The reaction was let stir for 1 hour at room 
temperature.  The base was neutralized with DOWEX 50WX8 (H+) cation exchange resin until 
neutral pH (~7)  was achieved.  The resin was filtered and rinsed with methanol.  The methanol 
was removed in vacuo and trace methanol or water was removed by co-evaporation with toluene 
(3 x 10 ml).  The crude product was used directly in the next step.  To flask containing the crude 
product was added imidazole (1.04 g, 15.3 mmol), then the flask was purged with argon, and the 
solids were dissolved in DMF (10 ml).  To the reaction was added t-butylchloro(diphenyl)silane 
(1.59 ml, 6.1 mmol) and the reaction was let stir for 8 hours at room temperature.  The reaction 
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was quenched with the addition of DI water (40 ml), EtOAc (30 ml) and allowing to stir for an 
additional 2 hours.  The layers were separated and the aqueous layer was extracted with EtOAc 
(2 x 30 ml).  The combined organic layers were washed with DI water (3 x 100 ml), brine (3 x 
100 ml) and dried over Na2SO4.  The organic solvent was removed in vacuo and the crude was 
purified by flash column chromatography on silica gel (20% to 50% EtOAc gradient in hexanes) 
to afford 34 (2.1 g, 3.82 mmol, 73%) as a pale yellow oil that turned into a white foam under 
high vac.   
 
1H NMR (CDCl3, 400 MHz) δ 7.76 – 7.61 (m, 4H), 7.50 – 7.30 (m, 6H), 7.02 (d, J = 9.1 Hz, 
2H), 6.86 – 6.76 (m, 2H), 5.47 (d, J = 3.5 Hz, 0.75H), 4.73 (d, J = 8.1 Hz, .25H), 4.24 (s, 1.5H), 
4.09 – 4.05 (m, 0.25H), 4.05 – 3.89 (m, 2.75H), 3.85 (dd, J = 10.0, 8.1 Hz, 0.25H), 3.77 (s, 3H), 
3.66 (dd, J = 10.0, 3.4 Hz, 0.75H), 3.57 (dd, J = 9.1, 3.6 Hz, 0.25H), 3.48 (s, 0.75H), 3.15 (d, J = 
3.3 Hz, 0.25H), 2.92 (d, J = 6.9 Hz, 0.75H), 1.08 (d, J = 5.6 Hz, 9H);  
 
13C NMR (CDCl3, 100 MHz) δ 155.79, 155.55, 151.41, 150.98, 135.96, 135.90, 135.76, 132.90, 
132.74, 130.24, 128.12, 128.07, 118.77, 118.47, 114.90, 114.82, 102.13, 98.54, 74.71, 72.59, 
70.35, 70.23, 68.85, 68.77, 64.50, 64.27, 63.89, 60.73, 60.57, 55.91, 27.03, 21.31, 19.39, 14.45.  
 
HRMS Calcd for [M+Na]+: 572.2193 Found: 572.2198. 
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Synthesis of p-methoxyphenyl 4-O-acetyl-2-deoxy-2-azido-6-O-t-
butyldiphenylsilyl-3-O-Levulinoyl-α/β-D-galactoside (35):  To a solution of compound 
34 (1.78 g, 3.34 mmol) and p-toluenesulfonic acid monohydrate (63 mg, 0.33 mmol) in toluene 
(10 ml) was added trimethylorthoacetate (4.24 ml, 33.34 mmol).  The reaction was let stir for 1 
hour, until compound 34 was completely consumed by TLC, at room temperature.  The solvent 
was removed in vacuo to afford a pale yellow oil that was used directly in the next step.  To the 
crude was added aqueous 80% acetic acid (10 ml) and the reaction was let stir for 1-2 hour, until 
the orthoester intermediate was completely consumed by TLC,  at 40 °C.  The reaction was 
diluted with water (40 ml) and extracted with methylene chloride (3 x 50 ml).  The combined 
organic layer was washed with DI water (3 x 150 ml), sat. sodium bicarbonate (3 x 150 ml), and 
dried over Na2SO4.  The organic layer was removed in vacuo to afford a yellow oil.  Trace 
amounts of water or acetic acid were removed by coevaporating with toluene (3 x 10 ml).  The 
crude intermediate, EDC (0.96 g, 5.0 mmol), and DMAP (40 mg, 0.3 mmol) were dissolved in 
methylene chloride (10 ml).  To the reaction was added levulinic acid (0.51 ml, 5.0 mmol) and 
triethylamine (0.7 ml, 5.0 mmol).  The reaction was let stir for 8 hours at room temperature.  The 
reaction was diluted with methylene chloride (100 ml) and washed with 2N HCl (2 x 200 ml), DI 
water (2 x 200 ml), sat. sodium bicarbonate (2 x 200 ml), and dried over Na2SO4.  The organic 
solvent was removed in vacuo and the crude product was purified by column chromatography on 
silica gel (20% to 30% EtOAc in hexanes) to afford 35 (1.89 g, 2.74 mmol, 85%) as a pale 
yellow syrup that turned to a white foam under high vac.   
1H NMR (CDCl3, 400 MHz) δ 7.68 – 7.50 (m, 4H), 7.48 – 7.30 (m, 6H), 7.03 (d, J = 9.1 Hz, 
2H), 6.79 (d, J = 9.1 Hz, 2H), 5.66 – 5.53 (m, 1.6H), 5.46 (d, J = 3.4 Hz, 1H), 4.90 – 4.73 (m, 
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0.4H), 4.28 (t, J = 6.7 Hz, 0.8H), 3.98 – 3.50 (m, 6H), 2.68 (m, 4H), 2.20 (d, J = 1.8 Hz, 3H), 
2.03 (d, J = 3.3 Hz, 3H), 1.01 (d, J = 15.0 Hz, 9H);  
 
 13C NMR (125 MHz, CDCl3) δ 205.92, 171.71, 171.61, 169.93, 169.83, 155.74, 155.58, 150.93, 
150.49, 135.57, 135.53, 135.49, 132.85, 132.79, 132.68, 129.97, 129.88, 129.84, 127.86, 127.82, 
127.80, 127.79, 118.54, 118.49, 114.70, 114.60, 101.76, 98.33, 73.84, 71.54, 69.91, 68.69, 67.62, 
66.43, 61.71, 61.03, 57.68, 55.51, 37.80, 37.76, 29.64, 27.88, 27.80, 26.73, 26.71, 20.53, 19.03.  
 
HRMS Calcd for [M+Na]+: 712.2666 Found: 712.2639.  
 
 
 
Synthesis of 4-O-acetyl-2-deoxy-2-azido-6-O-t-butyldiphenylsilyl-3-O-Levulinoyl-
α/β-D-galactopyranose trichloroacetimidate (23):   To a solution of compound 35 (1.88 
g, 2.72 mmol) in a mixture of acetonitrile and water (90 ml, 4:1 acetonitrile/water) stirring at 0 
°C in an ice bath was added solid ceric ammonium nitrate (4.47 g, 8.16 mmol).  The reaction was 
removed from the ice bath and let warm to room temperature.  The reaction was let stir for 10 
minutes at room temperature.  The reaction was diluted with DI water (200 ml) and extracted 
with ethyl acetate (3 x 100 ml ).  The organic fractions were pooled and washed with DI water (3 
x 200 ml), sat. sodium bicarbonate (3 x 200 ml) and dried over Na2SO4.  The solvent was 
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removed in vacuo and the crude oil was filtered over a plug of silica gel (20% to 50% EtOAc in 
hexanes) to afford an impure orange oil.  The compound was pure enough to be used in the next 
step. To a solution of the crude product in methylene chloride (22 ml) was added 
trichloroacetonitrile (2.73 ml, 27.2 mmol) and DBU (20 µl, 0.03 mmol).  The reaction was let stir 
for 1 hour at room temperature.  The solvent was removed in vacuo and purified by flash column 
chromatography on silica gel (20% EtOAc and 1% triethylamine in hexanes) to afford compound 
23 (1.23 g, 1.69 mmol, 63%) as a pale yellow oil which turned to a white foam under high vac.   
 
1H NMR (400 MHz, CDCl3) δ 8.74 (d, J = 7.3 Hz, 1H), 7.72 – 7.52 (m, 4H), 7.51 – 7.31 (m, 
6H), 6.46 (d, J = 3.5 Hz, 0.5H), 5.75 – 5.66 (m, 1H), 5.56 (d, J = 2.9 Hz, 0.5H), 5.43 (dd, J = 
11.1, 3.1 Hz, 0.5H), 4.94 (dd, J = 10.7, 3.3 Hz, 0.5H), 4.29 (t, J = 6.9 Hz, 0.5H), 4.02 – 3.86 (m, 
1H), 3.68 (dddd, J = 17.8, 15.0, 10.1, 6.8 Hz, 2H), 2.95 – 2.41 (m, 4H), 2.28 – 1.95 (m, 6H), 1.00 
(d, J = 6.2 Hz, 9H).  
 
13C NMR (100 MHz, CDCl3) δ 206.35, 171.89, 171.81, 170.18, 170.06, 161.02, 160.94, 135.87, 
135.78, 133.08, 130.14, 130.10, 128.03, 128.01, 97.03, 94.90, 91.01, 74.47, 72.10, 71.84, 69.46, 
67.23, 66.31, 61.52, 61.16, 60.99, 57.58, 38.10, 38.07, 30.04, 28.09, 28.02, 26.95, 26.91, 20.90, 
20.84, 19.32, 19.29.   
 
HRMS Calcd for [M+Na]+: 751.1322 Found: 751.1292. 
 
82 
 
 
Synthesis of p-methoxyphenyl 4,6-O-benzylidene-3-O-t-butyldimethylsilyl-β-D-
galactoside (37): To a solution of p-methoxyphenyl 4,6-O-benzylidene-β-D-galactoside (7.45 
g, 19.9 mmol) and imidazole (3.39 g, 50 mmol) in DMF (50 ml) was added t-
butylchlorodimethylsilane (3.9 g, 26 mmol).  The reaction was let stir for 24 hours at room 
temperature.  The reaction was quenched with addition of DI water (300 ml) and EtOAc (200 
ml) and the reaction was let stir for an additional 2 hours at room temperature.  The layers were 
separated and the aqueous layer was extracted one time with EtOAc (200 ml).  The combined 
organic layers were washed with DI water (3 x 400 ml) and dried over Na2SO4.  The crude 
product was purified by column chromatography on silica gel (50% EtOAc in hexanes) to afford 
37 (6.43 g, 13.2 mmol, 66%) as a colorless oil that turned to a white foam under high vac.  
 
1H NMR (CDCl3, 400 MHz) δ 7.60 – 7.49 (m, 2H), 7.40 – 7.30 (m, 3H), 7.06 (d, J = 9.0 Hz, 
2H), 6.80 (d, J = 9.0 Hz, 2H), 5.53 (s, 1H), 4.79 (d, J = 7.8 Hz, 1H), 4.35 (d, J = 12.3 Hz, 1H), 
4.06 (dt, J = 9.8, 7.0 Hz, 3H), 3.83 – 3.74 (m, 4H), 3.49 (s, 1H), 0.93 (s, 9H), 0.15 (d, J = 4.6 Hz, 
6H);  
 
13C NMR (CDCl3, 100 MHz) δ 13C NMR (101 MHz, cdcl3) δ 155.62, 151.62, 138.16, 128.97, 
128.27, 126.43, 119.41, 114.62, 102.93, 101.08, 76.57, 74.35, 70.81, 69.44, 67.04, 55.86, 26.01, 
18.51, -4.08, -4.37;  
 
HRMS Calcd for [M+Na]+: 511.2128 Found: 511.2123. 
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Synthesis of p-methoxyphenyl 2-O-acetyl-4,6-O-benzylidene-β-D-galactoside (38):  
To a solution of 37 (6.33 g, 13.0 mmol) and DMAP (159 mg, 1.3 mmol) in methylene chloride 
(40 ml) was added triethylamine (10.8 ml, 77.7 mmol) and acetic anhydride (4.9 ml, 52 mmol).  
The reaction was let stir for 8 hours at room temperature.  The reaction was diluted with 
methylene chloride (260 ml) and washed with DI water(3 x 300 ml), sat. sodium bicarbonate(3 x 
300 ml), and dried over Na2SO4.  The solvent was removed in vacuo and any trace water was 
coevaporated with toluene (3 x 25 ml) to afford a crude white solid.  To crude product in DMF 
(20 ml) was added triethylamine (7.22 ml, 51.8 mmol) and triethylamine trihydrogen fluoride 
complex (4.22 ml, 25.9 mmol).  The reaction was let stir for 72 hours at room temperature.  The 
reaction was quenched with the addition of DI water (200 ml).  The precipitate was filtered and 
recrystallized from CHCl3/hexanes mixture to afford 38 (3.68 g, 8.84 mmol, 68%) as a white 
solid.  
 
1H NMR (400 MHz, CDCl3) δ 7.53-7.50 (m, 2H), 7.37-7.36 (m, 3H), 6.99 (d, J = 9.1 Hz, 2H), 
6.80 (d, J = 9.1 Hz, 2H), 5.54 (s, 1H), 5.30 (dd, J = 9.9, 8.1 Hz, 1H), 4.87 (d, J = 8.0 Hz, 1H), 
4.40 – 4.30 (m, 1H), 4.23 (d, J = 3.5 Hz, 1H), 4.07 (dd, J = 12.5, 1.5 Hz, 1H), 3.89 – 3.67 (m, 
4H), 3.54 (s, 1H), 2.88 (d, J = 24.9 Hz, 1H), 2.13 (d, J = 3.3 Hz, 3H).  
 
13C NMR (100 MHz, CDCl3) δ 170.42, 155.49, 151.22, 137.23, 129.27, 128.21, 126.42, 118.91, 
114.41, 101.46, 100.55, 75.34, 71.96, 71.55, 68.81, 66.59, 55.58, 25.44, 20.94.   
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HRMS Calcd for [M+Na]+: 439.1369 Found: 439.1353. 
 
Synthesis of p-methoxyphenyl 2-O-acetyl-4,6-O-benzylidene-3-O-levulinoyl-β-D-
galactoside (39):   To a solution of compound 23 (3.56 g, 8.55 mmol), EDC (2.46 g, 12.8 
mmol), and DMAP (104 mg, 0.86 mmol) in methylene chloride (20 ml) was added levulinic acid 
(1.31 ml, 12.8 mmol) and triethylamine (1.8 ml, 12.8 mmol).  The reaction was let stir for 8 
hours at room temperature.  The reaction was diluted with methylene chloride (280 ml), the 
organic layer was washed with 5% CuSO4(aq) (2 x 200 ml), DI water (2 x 200 ml), sat. sodium 
bicarbonate (2 x 200 ml) and dried over Na2SO4.  The solvent was removed in vacuo and the 
crude oil was purified by column chromatography on silica gel (20% to 30% EtOAc in hexanes) 
to afford compound 39 (3.56 g, 6.80 mmol, 80%) as a pale yellow oil that turned to a white foam 
under high vac.  1H  
 
1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J = 7.5, 2.0 Hz, 2H), 7.38 (dd, J = 4.8, 2.4 Hz, 3H), 7.06 
– 6.94 (m, 2H), 6.87 – 6.76 (m, 2H), 5.60 (dd, J = 10.4, 8.0 Hz, 1H), 5.52 (s, 1H), 5.05 (dd, J = 
10.4, 3.6 Hz, 1H), 4.96 (d, J = 8.0 Hz, 1H), 4.36 (dd, J = 13.2, 2.2 Hz, 2H), 4.08 (dd, J = 12.5, 
1.7 Hz, 1H), 3.77 (s, 3H), 3.59 (d, J = 0.9 Hz, 1H), 2.80 – 2.50 (m, 4H), 2.09 (d, J = 13.4 Hz, 
6H).   
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13C NMR (100 MHz, cdcl3) δ 206.56, 172.39, 169.79, 155.91, 151.53, 137.75, 129.41, 128.46, 
126.77, 119.40, 114.74, 101.45, 101.30, 73.53, 72.26, 69.12, 68.68, 66.79, 55.93, 38.03, 29.92, 
28.50, 21.16.   
 
HRMS Calcd for [M+Na]+: 537.1736  Found [M+Na]+: 537.1732, [2M+Na]+: 1051.3625.  
 
 
Synthesis of 2-O-acetyl-4,6-O-benzylidene-3-O-levulinoyl-β-D-galactopyranose 
trichloroacetimidate (24):  To a solution of compound 39 (3.46 g, 6.73 mmol) in a mixture of 
acetonitrile and water (225 ml, 4:1 acetonitrile/water) stirring at 0 °C in an ice bath was added 
solid ceric ammonium nitrate (11.1 g, 20.2 mmol).  The reaction was removed from the ice bath 
and was let stir for 10 minutes..  The reaction was diluted with DI water (500 ml) and extracted 
with ethyl acetate (3 x 150 ml).  The organic fractions were pooled and washed with sat. sodium 
bicarbonate (3 x 500 ml) and brine (3 x 500 ml) dried over Na2SO4.  The solvent was removed in 
vacuo and the crude oil was purified by column chromatography on silica gel (20% to 30% 
EtOAc in hexanes) to afford impure compound  an orange oil.  The compound was pure enough 
to be used in the next step.  To a solution of the crude intermediate in methylene chloride (60 ml) 
was added trichloroacetonitrile (6.75 ml, 67.3 mmol) and DBU (50 µl, 0.33 mmol).  The reaction 
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was let stir for 1 hour at room temperature.  The solvent was removed in vacuo and purified by 
flash column chromatography on silica gel (20% EtOAc and 1% triethylamine in hexanes) to 
afford compound 24 (3.86 g, 6.99 mmol, 82%) as a pale yellow oil which turned to a white foam 
under high vac.  
 
1H NMR (500 MHz, CDCl3) δ 8.79 (s, 1H), 6.47 (d, J = 3.5 Hz, 1H), 5.67 (d, J = 8.5 Hz, 1H), 
5.49 (d, J = 2.2 Hz, 1H), 5.40 – 5.27 (m, 1H), 4.89 (dd, J = 10.8, 3.4 Hz, 1H), 4.37 (t, J = 6.4 Hz, 
1H), 4.17 – 3.98 (m, 3H), 3.92 (dd, J = 10.7, 8.5 Hz, 1H), 2.86 – 2.41 (m, 4H), 2.21 – 1.90 (m, 
9H).  
 
13C NMR (100 MHz, cdcl3) δ 206.44, 172.33, 170.33, 161.21, 137.64, 129.42, 128.50, 126.55, 
101.22, 94.83, 91.26, 73.63, 69.02, 68.78, 67.10, 65.00, 38.02, 29.96, 28.39, 20.87.   
 
HRMS Calcd for [M+Na]+: 574.0414 Found:574.0427. 
 
Synthesis of p-methoxyphenyl 2,4-O-diacetyl-6-O-t-butyldiphenylsilyl-β-D-
galactoside (41):  To a solution of compound p-methoxyphenyl 6-O-t-butyldiphenylsilyl-β-D-
galactoside (16.7 g, 32.8 mmol) and p-toluenesulfonic acid monohydrate (0.63 g, 3.28 mmol) in 
toluene (100 ml) was added trimethylorthoacetate (42 ml, 3.28 mmol).  The reaction was let stir 
for 1 hour, until the starting material was completely consumed by TLC analysis, at room 
temperature.  The solvent was removed in vacuo to afford a pale yellow oil that was used directly 
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in the next step.  Trace methanol and water was removed by coevaporation with toluene (3 x 25 
ml).  To the crude oil was added methylene chloride (100 ml), triethylamine (27 ml, 197 mmol), 
and acetic anhydride (9.31 ml, 98.5 mmol).  The reaction was let stir for 6 hours at room 
temperature.  The reaction was diluted with methylene chloride (300 ml), washed with sat. 
sodium bicarbonate (3 x 400 ml), and dried over Na2SO4.  The solvent was removed in vacuo to 
afford a pale yellow oil which was used directly in the next step.  To the crude oil was added 
aqueous 80% acetic acid (75 ml) and the reaction was let stir for 1-2 hour, until the intermediate 
was completely consumed, at 40 °C.  The reaction was diluted with water (350 ml) and extracted 
with methylene chloride (3 x 200 ml).  The combined organic layer was washed with DI water (3 
x 400 ml), sat. sodium bicarbonate (3 x 400 ml), and dried over Na2SO4.  The organic layer was 
removed in vacuo to afford  a light yellow oil that turned to a white solid if let sit over night.  
The crude product was purified by recrystallization from a CHCl3/hexanes mixture to provide 41 
(12.6 g, 51.26 mmol, 65%) as a white amorphous solid.   
 
1H NMR (CDCl3, 400 MHz) δ 7.69 – 7.58 (m, 4H), 7.40 (ddd, J = 9.3, 7.6, 2.1 Hz, 6H), 7.02 – 
6.91 (m, 2H), 6.81 – 6.72 (m, 2H), 5.45 (d, J = 3.5 Hz, 1H), 5.21 (dd, J = 10.0, 8.0 Hz, 1H), 4.87 
(d, J = 7.9 Hz, 1H), 3.96 – 3.88 (m, 1H), 3.83 – 3.72 (m, 6H), 2.69 (d, J = 5.5 Hz, 1H), 2.15 (s, 
3H), 2.07 (s, 3H), 1.06 (s, 9H) ;  
 
13C NMR (CDCl3, 100 MHz) δ 171.43, 171.29, 155.74, 151.57, 135.86, 135.84, 133.21, 133.11, 
130.19, 130.09, 128.09, 128.04, 118.71, 114.79, 100.74, 74.42, 72.97, 72.05, 70.05, 62.18, 55.92, 
27.04, 21.26, 21.06, 19.39;.  
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HRMS Calcd for [M+Na]+: 631.2339 Found [M+Na]+: 631.2348, [2M+Na]+: 1239.4775. 
 
 
Synthesis of p-methoxyphenyl 2,4-O-diacetyl-6-O-t-butyldiphenylsilyl-3-O-
Levulinoyl-β-D-galactoside (42):  To a solution of compound 41 (12.28 g, 20.21 mmol), 
EDC (5.81 g, 30.3 mmol), and DMAP (247 mg, 2.02 mmol) in methylene chloride (100 ml) was 
added levulinic acid (3.1 ml, 30.3 mmol) and triethylamine (4.22 ml, 30.3 mmol).  The reaction 
was let stir for 8 hours at room temperature.  The reaction was diluted with methylene chloride 
(300 ml), the organic layer was washed with 2N HCl (2 x 400 ml), DI water (2 x 400 ml), sat. 
sodium bicarbonate (2 x 400 ml), and dried over Na2SO4.  The solvent was removed in vacuo 
and the crude oil was purified by column chromatography on silica gel (20% to 50% EtOAc in 
hexanes) to afford compound 42 (12.71 g, 18.0 mmol, 89%) as a pale yellow oil that turned to a 
white foam under high vac.  
 
1H NMR (400 MHz, CDCl3) δ 7.67 – 7.51 (m, 4H), 7.37 (dt, J = 14.3, 7.0 Hz, 6H), 6.93 (d, J = 
8.8 Hz, 2H), 6.74 (d, J = 8.8 Hz, 2H), 5.49 (s, 1H), 5.47 – 5.32 (m, 1H), 5.08 (dd, J = 10.4, 2.8 
Hz, 1H), 4.88 (d, J = 8.0 Hz, 1H), 3.84 (t, J = 6.4 Hz, 1H), 3.81 – 3.73 (m, 1H), 3.72 (s, 3H), 3.69 
– 3.63 (m, 1H), 2.80 (d, J = 7.6 Hz, 4H), 2.17 – 1.98 (m, 9H), 1.01 (s, 9H).   
 
13C NMR (100 MHz, CDCl3) δ 206.14, 171.68, 170.13, 169.63, 155.51, 151.15, 135.54, 135.53, 
132.78, 132.66, 129.88, 129.79, 127.78, 127.74, 118.46, 114.48, 100.73, 73.76, 71.37, 68.78, 
67.09, 61.49, 55.59, 37.64, 29.64, 27.80, 26.67, 20.76, 20.65, 19.01.    
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HRMS Calcd for [M+Na]+: 729.2707 Found: 729.2691. 
 
 
Synthesis of 2,4-O-diacetyl-6-O-t-butyldiphenylsilyl-3-O-Levulinoyl-β-D-
galactopyranose trichloroacetimidate (25):  To a solution of compound 42 (2.91 g, 4.22 
mmol) in a mixture of acetonitrile and water (137 ml, 4:1 acetonitrile/water) stirring at 0 °C in an 
ice bath was added solid ceric ammonium nitrate (5.59 g, 12.35 mmol).  The reaction was 
removed from the ice bath and was let stir for 10 minutes.  The reaction was diluted with DI 
water (300 ml) and extracted with ethyl acetate (3 x 100 ml).  The organic fractions were pooled 
and washed with sat. sodium bicarbonate (3 x 200 ml), brine (3 x 200 ml) and dried over 
Na2SO4.  The solvent was removed in vacuo and the crude oil was filtered through a plug of 
silica gel (20% to 50% EtOAc in hexanes) to give an impure orange oil.  The compound was 
pure enough to be used in the next step.  To a the crude product in methylene chloride (20 ml) 
was added trichloroacetonitrile (4.13 ml, 41.2 mmol) and DBU (30  µl, 0.41 mmol).  The 
reaction was let stir for 1 hour at room temperature.  The solvent was removed in vacuo and 
purified by flash column chromatography on silica gel (20% EtOAc and 1% triethylamine in 
hexanes) to afford compound 25 (2.48 g, 3.32 mmol, 81% ) as a pale yellow oil which turned to 
a white foam under high vac.  
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1H NMR (400 MHz, CDCl3) δ 8.63 (d, J = 23.8 Hz, 1H), 7.58 (d, J = 6.9 Hz, 4H), 7.38 (tdd, J = 
14.6, 6.2, 2.4 Hz, 6H), 6.53 (d, J = 3.7 Hz, 1H), 5.84 (d, J = 8.3 Hz, 1H), 5.64 (dd, J = 37.5, 2.4 
Hz, 1H), 5.47 (dd, J = 10.8, 3.2 Hz, 1H), 5.34 (dd, J = 10.8, 3.7 Hz, 1H), 5.16 (dd, J = 10.5, 3.4 
Hz, 1H), 4.30 (t, J = 6.9 Hz, 1H), 4.02 (dt, J = 13.8, 6.5 Hz, 1H), 3.82 – 3.56 (m, 2H), 2.90 – 2.36 
(m, 4H), 2.17 (d, J = 6.5 Hz, 3H), 2.08 – 2.00 (m, 6H), 1.01 (d, J = 5.9 Hz, 9H).   
 
13C NMR (100 MHz, CDCl3) δ 206.55, 171.90, 170.56, 170.27, 161.22, 135.89, 135.80, 133.12, 
130.13, 130.09, 128.04, 128.00, 110.30, 96.38, 93.92, 91.17, 71.73, 68.34, 67.73, 67.27, 61.51, 
37.97, 30.05, 28.06, 26.96, 26.93, 20.95, 20.88, 20.85, 19.33.   
 
HRMS Calcd for [M+Na]+: 766.1385 Found: 766.1368. 
 
 
General Synthesis of 1H,1H,2H,2H,3H,3H-perfluoroundecyloxybutenyl 2-deoxy-2-
azido-4,6-O-benzylidene-3-O-Levulinoyl-α/β-D-galactopyranoside (43/44):  To a 
solution of 1H,2H,2H,3H,3H-perfluoroundecyloxybutenyl alcohol (~67 µmol, 1 eq.) in solvent 
was added thiophene (~670 µmol, 10 eq.), if used, and donor 17 (~200 µmol, 3 eq.).  The 
reaction was let stir for 30 minutes while allowing for the mixture to reach the desired 
temperature.  A solution of TMSOTf in methylene chloride (0.9 ml of 230 mmol, ~20 µmol, 0.3 
eq.) was added to the reaction while stirring.  The products were easily separable by column 
91 
 
 
chromatography on silica gel (20% EtOAc in hexanes) to give compounds 43 and 44 as colorless 
oils.  Anomeric assignments were based on COSY experiments to identify Hanomeric and 1H to 
determine coupling constant.   
Table III. Glycosylation conditions.  All reactions were run at 0.4M with respect to donor 17.  
*Reaction was run at 0.01M with respect to donor 17. 
Entry Solvent Thiophene Temperature Yield Selectivity 
1 CH2Cl2 N/A 25 °C 80 All β 
2 CH2Cl2 10 eq. 0 °C 70 1.2:1 α/β 
3 CH2Cl2 10 eq. 25 °C 73 1.1:1 α/β 
4 Et2O N/A 0 °C 30 2.5:1 α/β 
5* Et2O N/A 0 °C 82 3.5:1 α/β 
 
Compound 43 (α): Hanomeric at 5.04 (d, J = 3.2 Hz) 
1H NMR (400 MHz, cdcl3) δ 7.49 (dd, J = 6.7, 2.9 Hz, 1H), 7.45 – 7.33 (m, 1H), 5.76 (q, J = 5.7 
Hz, 1H), 5.59 (s, 1H), 5.04 (d, J = 3.4 Hz, 1H), 4.44 – 3.96 (m, 4H), 3.77 (s, 1H), 3.61 (dd, J = 
10.5, 3.4 Hz, 1H), 3.50 (t, J = 6.0 Hz, 1H), 2.43 (d, J = 10.8 Hz, 1H), 2.30 – 2.08 (m, 1H), 1.89 
(dd, J = 10.1, 5.7 Hz, 1H). 
Compound 44 (β):  Hanomeric at 4.33 (d, J = 8 Hz) 
1H NMR (400 MHz, cdcl3) δ 7.45 (dd, J = 7.3, 2.1 Hz, 2H), 7.30 (dd, J = 4.9, 2.3 Hz, 3H), 5.80 
– 5.63 (m, 2H), 5.46 (s, 1H), 4.68 (dd, J = 10.8, 3.5 Hz, 1H), 4.44 (dd, J = 12.5, 5.6 Hz, 1H), 4.33 
(d, J = 8.0 Hz, 1H), 4.29 – 4.13 (m, 3H), 3.98 (dd, J = 8.7, 3.7 Hz, 3H), 3.84 (dd, J = 10.8, 8.0 
Hz, 1H), 3.41 (dd, J = 14.3, 8.3 Hz, 3H), 2.63 (dtd, J = 10.8, 7.1, 2.9 Hz, 4H), 2.22 – 2.00 (m, 
5H), 1.86 – 1.74 (m, 2H). 
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Synthesis of p-methoxyphenyl 2-deoxy-2-azido-4,6-O-[bis(t-Butyl)silylene]-α-D-
galactopyranoside (46):  To a solution of compound 30 (4.14 g, 9.46 mmol) in methanol (25 
ml) was added solid sodium (220  mg, 9.46 mmol).  The reaction was let stir for 1 hour at room 
temperature.  The base was neutralized with DOWEX 50WX8 (H+) cation exchange resin until 
neutral pH (~7)  was achieved.  The resin was filtered and rinsed with methanol.  The methanol 
was removed in vacuo and trace methanol or water was removed by co-evaporation with toluene 
(3 x 10 ml).  The crude product was used directly in the next step.  To flask containing the crude 
product was purged with argon and the material was dissolved in methylene chloride (20 ml).  
To the reaction was added pyridine (2.3 ml, 28.4 mmol) followed by the dropwise addition (~.8 
ml/min) of  di-tert-butylsilyl bus(trifluoromethanesulfonate) (3.7 ml, 11.35 mmol).  The reaction 
was let stir at rt for 10 hours. The reaction was diluted with methylene chloride the organic layer 
was washed with DI water (3 x 100 ml), brine (3 x 100 ml) and dried over Na2SO4.  The organic 
solvent was removed in vacuo and the crude was purified by flash column chromatography on 
silica gel (20% to 30% EtOAc gradient in hexanes) to afford 46 (2.74 g, 6.07 mmol, 64%) as a 
pale yellow oil that turned into a white foam under high vac.   
 
1H NMR (400 MHz, CDCl3) δ 7.04 (d, J = 9.0 Hz, 2H), 6.83 (d, J = 9.0 Hz, 2H), 4.69 (dd, J = 
21.1, 8.1 Hz, 1H), 4.42 (dd, J = 30.3, 3.0 Hz, 1H), 4.33 – 4.18 (m, 2H), 4.18 – 3.83 (m, 1H), 3.83 
– 3.69 (m, 4H), 3.61 – 3.36 (m, 2H), 2.79 (t, J = 18.1 Hz, 1H), 1.07 (d, J = 9.3, Hz, 18H).   
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13C NMR (100 MHz, CDCl3) δ 156.07, 151.41, 119.70, 119.66, 114.79, 102.56, 102.28, 76.99, 
73.86, 72.94, 72.65, 71.94, 71.72, 67.08, 64.49, 55.94, 27.77, 27.69, 27.61, 27.52, 23.69, 23.63, 
21.10, 20.98, 20.84.   
 
HMRS Calcd for [M+Na]+: 474.2036 Found: 474.2026. 
 
Synthesis of p-methoxyphenyl 2-deoxy-2-azido-3-O-Levulinoyl-4,6-O-[bis(t-
Butyl)silylene]-α-D-galactopyranoside(47):   To a solution of compound 46 (1.5 g, 3.32 
mmol), EDC (0.76 g, 3.99 mmol), and DMAP (41 mg, 0.33 mmol) in methylene chloride (12 ml) 
was added levulinic acid (0.41 ml, 3.99 mmol) and triethylamine (0.56 ml, 3.99 mmol).  The 
reaction was let stir for 8 hours at room temperature.  The reaction was diluted with methylene 
chloride (280 ml), the organic layer was washed with 2N HCl (2 x 200 ml), DI water (2 x 200 
ml), sat. sodium bicarbonate (2 x 200 ml) and dried over Na2SO4.  The solvent was removed in 
vacuo and the crude oil was purified by column chromatography on silica gel (20% to 30% 
EtOAc in hexanes) to afford compound 47 (1.5 g, 2.73 mmol, 82%) as a pale yellow oil that 
turned to a white foam under high vac.   
 
1H NMR (500 MHz, cdcl3) δ 7.13 – 6.98 (m, 2H), 6.92 – 6.72 (m, 2H), 4.72 (d, J = 8.0 Hz, 1H), 
4.62 – 4.55 (m, 2H), 4.26 – 4.17 (m, 2H), 4.04 (dd, J = 10.4, 8.0 Hz, 1H), 3.73 (d, J = 3.2 Hz, 
3H), 3.43 (s, 1H), 2.80 – 2.65 (m, 4H), 2.17 (s, 3H), 1.05 (d, J = 32.6 Hz, 18H).   
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13C NMR (125 MHz, CDCl3) δ 206.02, 172.20, 155.99, 151.20, 119.60, 114.68, 102.22, 74.25, 
71.32, 69.40, 67.01, 60.47, 55.74, 38.02, 29.90, 28.27, 27.65, 27.59, 23.41, 20.93. 
 
HRMS Calcd for [M+Na]+: 537.1736  Found [M+Na]+: 537.1732, [2M+Na]+: 1051.3625.  
 
 
 
Synthesis of 2-deoxy-2-azido-3-O-Levulinoyl-4,6-O-[bis(t-Butyl)silylene]-α-D-
galactose trichloroacetimidate(45):   To a solution of compound 47 (1.38 g, 2.56 mmol) in 
a mixture of acetonitrile and water (75 ml, 4:1 acetonitrile/water) stirring at 0 °C in an ice bath 
was added solid ceric ammonium nitrate (4.13 g, 8.08 mmol).  The reaction was removed from 
the ice bath and let stir for 10 minutes.  The reaction was diluted with DI water (150 ml) and 
extracted with ethyl acetate (3  x  75 ml).  The organic fractions were pooled and washed with 
sat. sodium bicarbonate (3 x 200 ml), brine (3 x 200 ml) and dried over Na2SO4.  The solvent 
was removed in vacuo and the crude oil was filtered over a plug of silica gel (20% to 50% 
EtOAc in hexanes) to afford the impure hemiacetal as an orange oil.  The compound was pure 
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enough to be used directly in the next step.  To the crude in methylene chloride (5 ml) was added 
trichloroacetonitrile (0.60 ml, 6.03 mmol) and DBU (30 µl, 0.2 mmol).  The reaction was let stir 
for 1 hour at room temperature.  The solvent was removed in vacuo and purified by flash column 
chromatography on silica gel (10% EtOAc and 1% triethylamine in hexanes) to afford compound 
45 (1.01 g, 1.72 mmol, 67%) as a pale yellow oil which turned to a white foam under high vac.    
 
1H NMR (400 MHz, CDCl3) δ 8.73 (s, 1H), 6.49 (d, J = 3.5 Hz, 1H), 5.18 (dd, J = 10.9, 2.9 Hz, 
1H), 4.81 (d, J = 2.7 Hz, 1H), 4.30 – 4.12 (m, 3H), 3.97 (s, 1H), 2.88 – 2.64 (m, 4H), 2.20 (s, 
3H), 1.04 (d, J = 8.4 Hz, 18H).   
 
13C NMR (100 MHz, CDCl3) δ 206.08, 172.29, 160.96, 95.54, 91.03, 71.99, 69.92, 69.80, 66.68, 
56.85, 38.03, 29.99, 28.30, 27.73, 27.43, 23.44, 20.94. 
 
HRMS Calcd for [M+Na]+: 609.1082 Found: 609.1081. 
 
 
Synthesis of cis-3-(perfluorooctyl)propyloxy-2-butenyl 2-deoxy-2-azido-4,6-O-
[bis(t-Butyl)silylene]-α-D-galactoside(48):   To FtagOH (149 mg, 0.27 mmol) and 45 (400 
mg, 0.82 mmol) in methylene chloride (2.4 ml) was added TMSOTf (0.36 ml of 230 mM,  81 
µmol) at room temperature.  The reaction was quenched with 0.1 ml Et3N and the solvent was 
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removed in vacuo.  The crude was taken up in a mixture of pyridine and acetic acid (1 ml, 4:1 
Py/HOAc) to which was added allyl alcohol (0.14 ml, 2.04 mmol) and hydrizine hydrate (0.1 ml, 
2.04 mmol).  The reaction was let stir for 3 hours at room temperature.  To the reaction was 
added 0.2 ml water and the reaction mixture was loaded directly onto fluorofllash silica gel.  
Non-fluorous compounds were eluted with 80% MeOH(aq) and fluorous compounds were eluted 
with MeOH.  The fluorous containing fractions were concentrated and further purified by flash 
column chromatography to provide compound 48 (127 mg, 145 µmol, 53%) as a white foam. 
 
1H NMR (400 MHz, CDCl3) δ 5.74 (q, J = 4.8 Hz, 2H), 4.95 (d, J = 3.5 Hz, 1Hanomeric), 4.46 (d, J 
= 2.9 Hz, 1H), 4.33 – 4.26 (m, 1H), 4.23 – 4.12 (m, 3H), 4.02 (dd, J = 24.1, 7.9 Hz, 3H), 3.77 (s, 
1H), 3.52 – 3.43 (m, 3H), 2.63 (d, J = 10.4 Hz, 1H), 2.17 (td, J = 18.8, 9.8 Hz, 2H), 1.87 (td, J = 
11.8, 6.0 Hz, 2H), 1.04 (d, J = 13.9 Hz, 18H).   
 
13C NMR (101 MHz, CDCl3) δ 130.60, 128.18, 97.84, 73.14, 69.13, 68.98, 67.65, 67.07, 66.79, 
63.84, 60.91, 30.01, 27.83, 27.48, 23.65, 21.01.   
 
HRMS Calcd for [M+Na]+: 898.2156 Found: 898.2137. 
 
Synthesis of cis-3-(perfluorooctyl)propyloxy-2-butenyl 2,4-O-diacetyl-6-O-t-
butyldiphenylsilyl-3-O-Levulinoyl-β-D-galactopyranosyl-(1→3)-2-deoxy-2-azido-
4,6-O-[bis(t-Butyl)silylene]-α-D-galactoside(49):  A solution of 48 (38.8 mg, 49 µmol) 
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and 25 (99.0 mg, 133 µmol) in methylene chloride (0.5 ml)  was cooled to 0 °C in an ice bath.  
To the reaction  was added TMSOTf  (60 µl of a 230 mM solution in CH2Cl2, 5 µmol) and the 
reaction was let stir for 1 h.  The reaction was qunched with 50 µl of Et3N and the solvent was 
removed in vacuo.  The product was obtained after column chromatography on silica gel (25% 
EtOAc in hexanes) to give disaccharide 49 (62 mg, 42.5 mmol, 96%) as a colorless oil that 
turned into a white foam under vacuum.  
 
 1H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 7.4 Hz, 4H), 7.47 – 7.35 (m, 6H), 5.80 – 5.63 (m, 
2H), 5.48 (d, J = 2.8 Hz, 1H), 5.27 (dd, J = 10.2, 7.9 Hz, 1H), 5.02 (dd, J = 10.3, 3.2 Hz, 1H), 
4.92 (d, J = 3.3 Hz, 1H), 4.70 (d, J = 7.7 Hz, 1H), 4.63 (s, 1H), 4.27 – 3.95 (m, 6H), 3.86 (dd, J = 
10.6, 2.3 Hz, 1H), 3.67 (ddd, J = 26.4, 17.2, 7.7 Hz, 5H), 3.47 (t, J = 5.4 Hz, 2H), 2.74 (ddd, J = 
35.6, 21.6, 6.4 Hz, 4H), 2.28 – 1.96 (m, 11H), 1.94 – 1.75 (m, 2H), 1.04 – 0.85 (m, 27H).   
 
13C NMR (100 MHz, CDCl3) δ 206.48, 172.01, 170.35, 170.10, 135.84, 135.79, 132.99, 130.56, 
130.29, 130.20, 128.26, 128.15, 128.12, 102.92, 97.79, 78.59, 73.29, 72.87, 72.02, 69.41, 69.12, 
67.90, 67.22, 67.05, 66.74, 63.55, 61.57, 58.76, 37.97, 29.92, 28.19, 27.69, 27.44, 26.97, 23.50, 
21.08, 20.88, 20.84, 19.31.   
 
HRMS Cacld for [M+Na]+: 1480.4441 Found: 1480.4481. 
 
Synthesis of cis-3-(perfluorooctyl)propyloxy-2-butenyl 2,4-O-diacetyl-3-O-
Levulinoyl-β-D-galactopyranosyl-(1→3)-2-deoxy-2-azido-α-D-galactoside(50) and 
cis-3-(perfluorooctyl)propyloxy-2-butenyl 2,6-O-diacetyl-3-O-Levulinoyl-β-D-
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galactopyranosyl-(1→3)-2-deoxy-2-azido-α-D-galactoside(51):  To solution of 49 (37.5 
mg, 25.7 µmol) in DMF (0.5 ml) was added Et3N (24 µl, 170 µmol) and Et3N(HF)3 (14 µl, 85 
µmol).  The reaction was let stir at room temperature for 72 hours.  The reaction was diluted with 
5 ml water and extracted with methylene chloride (3 x 5 ml) and washed with DI water (3 x 5 
ml) and brine (3 x 5 ml).  The solvent was removed in vacuo and the crude product was purified 
by column chromatography (3% to 5% MeOH in CH2Cl2) to give an inseparable mixture of 
compounds 50 and 51 (23 mg, 21.3 µmol, 83%).   
 
1H NMR (400 MHz, cdcl3) δ 5.84 – 5.67 (m, 2H), 5.33 (ddd, J = 27.9, 10.4, 7.8 Hz, 2H), 5.01 
(ddd, J = 9.8, 8.4, 3.5 Hz, 2H), 4.84 (dd, J = 10.3, 3.0 Hz, 1H), 4.71 (dd, J = 18.0, 8.0 Hz, 1H), 
4.39 (dd, J = 11.6, 7.5 Hz, 1H), 4.33 – 4.11 (m, 4H), 4.09 – 3.96 (m, 3H), 3.84 (ddd, J = 17.3, 
15.9, 8.1 Hz, 4H), 3.74 – 3.61 (m, 2H), 3.60 – 3.42 (m, 3H), 3.11 (s, 1H), 2.92 (d, J = 30.2 Hz, 
1H), 2.84 – 2.33 (m, 6H), 2.27 – 2.00 (m, 12H), 1.87 (td, J = 11.8, 6.1 Hz, 2H).   
 
13C NMR (100 MHz, CDCl3) δ 208.71, 206.32, 172.15, 171.98, 171.38, 171.10, 170.29, 170.24, 
130.78, 130.72, 128.13, 128.06, 102.36, 102.21, 97.76, 97.66, 78.66, 78.59, 77.63, 74.28, 74.13, 
72.78, 71.36, 69.80, 69.75, 69.58, 69.20, 68.85, 68.78, 67.97, 66.70, 63.68, 63.63, 63.09, 62.86, 
62.76, 61.25, 60.86, 58.95, 58.88, 38.46, 37.90, 30.00, 28.07, 21.02.   
 
HRMS Calcd for [M+Na]+: 1102.2242 Found: 1102.2212. 
 
Synthesis of cis-3-(perfluorooctyl)propyloxy-2-butenyl 2,3,4,6-tetra-O-acetyl-β-D-
glucopyranosyl-(1→6)-2,4-O-diacetyl-3-O-Levulinoyl-β-D-galactopyranosyl-(1→3)-( 
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2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1→4))-( 2,3,4,6-tetra-O-acetyl-β-D-
glucopyranosyl-(1→6))- ( 2-deoxy-2-azido-3-O-Levulinoyl-α-D-galactoside(10):  To 
a solution of 50 and 51 (18.7 mg, 17 µmol) and 27 (51 mg, 104 µmol) in methylene chloride (0.1 
ml) at 0 °C was added TMSOTf( 0.1 ml of a 500 µM solution, 500 nm).  The reaction was let stir 
for 1 hour.  The reaction was quenched with the addition of 50 µl Et3N and the solvent was 
removed in vacuo.  The residue was purified by column chromatography (3% to 5% MeOH in 
CH2Cl2) to produce either compound 10 or it's 4-O glycoylated regioisomer product (35 mg, 17 
µmol, 44%) as a colorless oil.   
 
HRMS Calcd for [M+Na]+: 2092.5059 Found: 2092.5139. 
NMR data is inconclusive, see appendex B. 
 
Automation of pentasaccharide 10 
Prepared stock solutions for glycosylation: 
Compound Concentration M Solvent 
45 0.8 CH2Cl2 
Ftag 0.26 CH2Cl2 
25 0.4 CH2Cl2 
27 0.4 CH2Cl2 
TMSOTf 0.23 CH2Cl2 
 
Prepared stock solutions for hydrolysis of levulinoyl ester was 0.25 M hydrazine hydrate and 
0.25 M allyl alcohol in 4:1 pyridine/acetic acid. 
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Prepared stock solution for cleavage of the silyl groups was 0.1M TBAF and 0.1M AcOH in 
DMF. 
Necessary reagents:  methanol, 80% aqueous methanol, water, DMF, Et3N and toluene.  The 
platform was set up according to the figure 3.7. 
   
Figure 3.7  Chemspeed platform set up.  Not pictured are toluene, methanol, %80 methanol and 
water, and TMSOTf.  Those are contained in larger reservoirs, except for TMSOTf, which is 
kept in a special location for moisture sensitive reagents. 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
Conclusions 
 
 Trifunctional affinity proteomics probes (TAPPs) featuring a signal to elicit binding 
interactions, a photoactivatable cross-linker to capture those proteins, and a solid resin exploited 
for captured protein purification have been synthesized.  Initial experiments were to develop a 
protocol to use these TAPPs as well as to test the ability of TAPPs to selectively capture known 
binding lectins with specificity for control glycans.  Incubation, cross-linking, and rinsing 
protocols were optimized to selectively capture purified proteins.  TAPPs with the perfluorinated 
phenylazide photo cross-linker exhibited greater sensitivity, about 3 fold increase in ion current 
for an ubiquitous peptide fragment.  Furthermore, the fluorinated TAPPs displayed greater 
selectivity when comparing ion current of positive controls to negative controls of fluorinated 
phenyl azide to phenyl azide.  The synthetic route was designed to make use of combinatorial 
chemical methods , such as automated synthetic methods of carbohydrates. 
 Reported in this dissertation is the development of synthetic routes to a series of 
monosaccharide donors that could be used on an automated platform to rapidly produce an array 
of related oligosaccharides from  C. elegans.  Attempts to automate, while unsuccessful in 
producing the target compound, did show the usefulness of a solution phase platform by 
allowing for easy determination of the problem step by TLC analysis, something that is not 
possible with solid phase methodology.   
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 One interesting feature of these oligosaccharides is the heavily branched singular 
saccharide units that feature a 3,4, and 6 glycosidic linkage.  Investigation of known chemical 
methods to affect such a coupling, as well as accomplishing multiple glycoslyations was 
achieved. 
 
 
Future Directions 
 
 Investigation into linker effects and resin supports might confer better behavior, in terms 
of senstivity and selectivity, of the TAPPs reported in this dissertation.  A host of questions can 
be raised about the surface density and display of the carbohydrates on the surface of the resin.  
The surface of the resin support is considered to be a highly amorphous surface.  It's possible the 
display of carbohydrates is not very conducive to binding.  Considering the results with 
capturing purified proteins, maybe the soluble protein has more freedom to distort and find a 
conformation for favorable binding.  It is also known that conA (the protein used in these 
experiments) exhibits shallow binding pockets (Kiessling 1996).  Possibly the shallow pockets 
on conA make it possible to still bind to mannose that is tethered very near to the surface of the 
resin. Potentially, there is some aryl aryl interaction between the probe and the surface of the 
resin that could causes the probe to not present well in solution. It's also possible the polystyrene 
based probe contracts in the aqueous environment, distorting, collapsing, or in some way having 
adverse effects on the display of the carbohydrate on the surface of the resin.  A switch to a 
differently designed probe that uses latex particles that are known to swell in aqueous systems 
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and to linkers that are more hydrophilic (ether based), presentation of the carbohydrates will 
improve and the overall outcome of the cross-linking will improve. 
 The utility of this probe to be create array-like carbohydrate screening with the added 
benefit of being able to capture that interaction from live bacteria or a protein mixture would be a 
great advancement to current methodology.  Another challenge for the TAPPs that would be 
interesting to exploit is to use libraries of compounds such as the saccharides from C. elegans 
and try to capture surface binding proteins directly from cell culture. 
 The saccharides from the C. elegans are accessible with current methodolgy.  The donors 
here should be able to complete the synthesis of the six oligosaccharides.  If there was need to 
circumvent the acyl migration of the acetate during desilylation because no condition is able to 
avoid it, a benzoyl ester could be employed.  These esters are well known to resist migration.  
The routes described here could easily be modified to do so.  Using trimethyl orthobenzoate 
instead of trimethyl orthoacetate during orthoester formation of the cis diols in the galactose and 
galactosamine based donors, then the corresponding ester after ring opening would be the desired 
benzoyl ester. 
 The automated synthesis of carbohydrates is severally lagged by the access to donor 
saccharides in large scale.  If convenient routes were available to crystallizable intermediates, as 
well as developing methods to access the more rare carbohydrates, then automation could be 
realize its full potential.  A lot of outlook on automation is focused on the idea that it is to 
produce materials.  It's possible that automation can be much more useful than as a 
manufacturing platform, it could be used to systematically explore carbohydrate chemistry.  It 
could be employed to study concentration effects, temperature effects, and solvent effects rapidly 
if there is access to a handful of carbohydrates on large scale.  If better protecting group 
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strategies are employed, the ASW could also be used to probe the effects of protecting groups as 
well.  Currently, the literature is limited to small subsets of reactions with little systematic, or 
contiguous, data that allows for complete understanding of the glycosylation reaction.  The 
reactions are also spread out over the hands of hundreds of chemists who do things just a 'little 
different' then the other guy.  Automation would be better suited for such data acquisition by 
minimizing random error in the glycosylation outcomes as well. 
 Once a thorough understanding of carbohydrate chemistry is realized, and as chemical 
biological methodology develops, probing the functions of carbohydrates in biological systems 
will become more rapid and easier.  Developing our understanding of disease, treatments, and 
generally rounding out the scientific paradigm. 
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APPENDIX A. CHAPTER II 1H NMR AND 13C NMR 
 
1H NMR spectrum of compound 3 in d6-DMSO at 400 Mhz 
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13C NMR spectrum of compound 3 in d6-DMSO at 100 Mhz. 
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1H NMR spectrum of compound 4 on 700 MHz Varian NMR in d6-DMSO at 400 Mhz. 
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13C NMR spectrum of compound 4 in d6-DMSO at 100 Mhz. 
119 
 
 
 
1H NMR spectrum of compound 5 in d6-DMSO at 400 Mhz. 
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13C NMR spectrum of compound 5 in d6-DMSO at 100 Mhz. 
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1H NMR spectrum of compound in d6-DMSO at 400 Mhz. 
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13C NMR spectrum of compound 13 in d6-DMSO at 100 Mhz. 
 
123 
 
 
 
1H NMR spectrum of compound 14 in d6-DMSO at 400 Mhz. 
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13C NMR spectrum of compound 14 in d6-DMSO at 100 Mhz. 
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1H NMR spectrum of compound 15 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 15 in d6-DMSO at 100 MHz. 
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1H NMR spectrum of compound 16 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 16 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 18 in CDCl3 at 400 MHz. 
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19F NMR spectrum of compound 18 in d6-DMSO at 400 Mhz. 
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13C NMR spectrum of compound 18 in d6-DMSO at 100 MHz. 
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1H NMR spectrum of compound 19  Needed a couple drops of d6-DMSO to dissolve in CDCl3 at 
400 MHz 
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1H NMR spectrum of compound 20 in CDCl3 at 400 MHz 
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1H NMR spectrum of compound 21 CDCl3 at 400 Mhz. 
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13C NMR spectrum of compound 21 CDCl3 at 100 Mhz. 
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1H NMR spectrum of compound 22 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 22 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 23 in CD3OD at 400 MHz. 
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13C NMR spectrum of compound 23 in CD3OD at 100 MHz 
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APPENDIX B. CHAPTER III 1H NMR AND 13C NMR 
 
1H NMR spectrum of compound 21 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 21 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 22 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 22 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 23 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 23 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 24 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 24 in CDCl3 at 100 MHz. 
148 
 
 
 
1H NMR spectrum of compound 25 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 25 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 30 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 30 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 31 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 31 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 32 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 32 in CDCl3 at 100 MHz. 
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!H NMR spectrum of compound 33 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 33 in CDCl3 at 100 MHz. 
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!H NMR spectrum of compound 34 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 34 in CDCl3 at 100 MHz. 
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!H NMR spectrum of compound 35 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 35 in CDCl3 at 100 MHz. 
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!H NMR spectrum of compound 37 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 37 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 38 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 38 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 39 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 39 in CDCl3 at 100 MHz. 
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!H NMR spectrum of compound 41 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 41 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 42 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 42 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 43 in CDCl3 at 400 MHz. 
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1H NMR spectrum of compound 44 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 45 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 45 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 46 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 46 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 47 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 47 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 48 in CDCl3 at 400 MHz. 
181 
 
 
 
13C NMR spectrum of compound 48 in CDCl3 at 100 MHz. 
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1H NMR spectrum of compound 49 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compound 49 in CDCl3 at 100 MHz. 
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1H NMR Mixture of 50 and 51 in CDCl3 at 400 MHz. 
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13C NMR spectrum of compounds 50 and 51 in CDCl3 at 100 MHz. 
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1H NMR at 800 MHz to try improve the resolution of the NMR of target 10 in CDCl3. 
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HMBC at 800 MHz for possible 10 in CDCl3. 
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APPENDIX C. CHAPTER 2 LC-ESI CHROMATOGRAMS 
 
 
 This section contains the extracted ion chromatograms for the cross linking experiments 
of chapter II.  The top plot is the integrated peak that corresponds to matched peptide fragment 
from Con A.  The bottom is the parent mass spectra for the middle of the integrated region.  The 
matched peptide is VGLSASTGLYK. 
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APPENDIX D. CHAPTER 2 MALDI-QTOF MASCOT RESULTS 
 
 
Figure D.1  MASCOT results for TAPP-HMan MALDI-QTOF experiments.  Score for 95% 
confidence cutoff is 57.  Matched proteins at 116 and 134 correspond to two different 
concanavalin A entries in the database.  The score at 134 matched fragment 
'R.VSSNGSPQGSSVGR.A'  while this same short sequence in the match 116 had 
'R.VSSNGSPEGSSVGR.A' so this fragment didn't match, lowering the score.   
 
 
Figure D.2  MASCOT results for TAPP-HGal MALDI-QTOF experiments.  Score for 95% 
confidence cutoff is 47.  Score for matched protein is 94 and belongs to concanavalin A. 
 
 
